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Summary
Many physiological processes exhibit circadian rhythms driven by cellular clocks
composed of interlinked activating and repressing elements. The far-reaching influence
of the circadian organization is illustrated by the fact that in each tissue ~10% of the
transcriptome is under the control of the circadian clock. Positive components are
heterodimers of CLOCK and BMAL1 that bind to E-box promoter elements of Period
and Cryptochome genes that encode repressor proteins CRY and PER. However,
important issues that the transcriptional/translational feedback loop leave unresolved are
(1) how binding of CLOCK-BMAL1 heterodimers to E-box promoter elements results in
RNA Pol II-mediated transcription and (2) how exactly CRY proteins interfere with this
process. Transcription is a highly complex process that is regulated at multiple levels.
Well-recognized, rate-limiting step is the RNA Pol II release from promoter-proximal
pause sites, which serves as a checkpoint, allowing rapid and synchronous expression of
genes. This pause release of RNA Pol II and the transition to productive elongation
requires the activity of the P-TEFb. P-TEFb is recruited by interaction with specific
factors such as BRD4 to gene promoters. BRD4 binds through its bromo-domains to
acetylated lysines of histones and of transcription factors present at the promoters, thereby
bringing P-TEFb to the site of action. Acetyltransferases that acetylate BRD4 binding
partners play an important role in regulating RNA Pol II pause release. Of particular
relevance for the present study is the lysine acetyltransferase TIP60. TIP60 is an essential
protein and is involved in a multitude of cellular processes that depend on lysine
acetylation of histone and non-histone proteins.
To investigate the temporal regulation of CLOCK-BMAL1-mediated transcription,
mouse genetic approaches and analyses of interactions of key circadian proteins with each
other and with E-box-containing clock gene promoters were combined. This approach
provided evidence that the positive and negative phases of the circadian oscillator are
linked through the acetyltransferase TIP60. The circadian clock cycle is initiated by
BMAL1 binding to E-boxes of clock genes followed by a TIP60-mediated acetylation of
chromatin bound BMAL1. This acetylation triggers recruitment of the BRD4-P-TEFb
complex to E-box-containing circadian promoters leading to RNA Pol II pause release
and productive elongation of circadian transcripts, including those encoding CRY and
PER proteins. The study further shows that CRY repressors compete with TIP60 for
BMAL1 to prevent TIP60 from acetylating BMAL1, thereby abolishing the binding of
BRD4-P-TEFb complexes to circadian promoters and thus inhibiting productive
Summary VI
transcript elongation. This competition characterizes the repressive limb of the clock
cycle and eventually culminates in a complete cessation of BMAL1 acetylation and, thus,
to the termination of clock gene transcription. Taken together, the experiments suggest
that control of BRD4-P-TEFb recruitment to E-box-containing circadian promoters is a
novel temporal checkpoint in the circadian clock cycle.
Abbreviations VII
Abbreviations
AdCre Adenovirus-expressing Cre recombinase
AdGFP Adenovirus-expressing green fluorescence protein
ANOVA analysis of variance
BAC Bacterial artificial chromosome
BMAL1 Brain and muscle ARNT-like protein 1
bp base pair
BRD4 Bromodomain-containing protein 4
BSA Bovine Serum Albumin
CCGs Clock-controlled output genes
CDK9 Cyclin-dependent kinase 9
ChIP Chromatin immunoprecipitation
CLOCK Circadian locomotor output cycles kaput
CMV Cytomegalovirus
Cre Cre recombinase
Cry Cryptochrome
CT Circadian time
DAPI 4′,6-diamidino-2-phenylindole
Dbp D-site albumin promoter binding protein
DD Constant darkness
ddH2O Double-distilled water
ddNTP Dideoxynucleotide triphosphate
Dex Dexamethasone
DMEM Dulbecco's Modified Eagle Medium
DNA Deoxyribonucleic acid
DTT Dithiothreitol
ECL Enhanced chemoluminescence
EDTA Ethylenediaminetetraacetic acid
EGTA Ethylene glycol tetraacetic acid
et al. et alii
EtOH Ethanol
FBS Fetal Bovine Serum
FP Flavopiridol
HDAC Histone deacetylase
IP Immunoprecipitation
JQ1 Triazolothienodiazepine
LD Light-dark cycle
LoxP locus of X-over P1
P-TEFb Positive transcription elongation factor b
PBS Phosphate buffered saline
PCR Polymerase chain reaction
Abbreviations VIII
Per Period
qPCR quantitative PCR
Rev-Erb Reverse erythroblastosis virus
RNA Pol II RNA Polymerase II
SCN Suprachiasmatic nucleus
SDS Sodium dodecyl sulfate
SEM Standard error of the mean
Syt10 Synaptotagmin 10
Tip60 60 kDa Tat-interactive protein
ZT Zeitgeber time
Chapter 1: Introduction 1
Chapter 1:  Introduction
1.1 The Circadian Clock
As a result of the Earth’s rotation, living organisms developed an internal timing system
called circadian clock that allows them to anticipate daily changes in their environment
such as light and dark, food availability or temperature fluctuations (Pittendrigh, 1993).
The term circadian derives from the Latin words circa (about) and diem (day) and
describes the approximately 24-hour oscillation of biological processes. In mammals, the
circadian oscillator controls daily rhythms of sleep and wakefulness, food and water
consumption, and cognitive and physical performance (Beersma and Gordijn, 2007;
Challet, 2019; Gerstner and Yin, 2010). Apart from behavior the circadian clock also
regulates a variety of physiological parameters such as body temperature, hormone
production and secretion, blood pressure, and numerous metabolic processes (Bass and
Takahashi, 2010; Green et al., 2008; Panda, 2016).
Anticipating recurrent events is not the only function of the circadian oscillator. It
provides additional important benefits for the organism, such as the temporal separation
of chemically incompatible biological processes and the restriction of potentially harmful,
but essential, chemical reactions to the times when they are required (Schibler et al.,
2015).
A remarkable feature of the circadian clock is that it persists in the absence of rhythmic
external time cues (zeitgebers) such as light or temperature. For example, mice kept under
constant darkness show robust locomotor activity rhythms with a free-running period
slightly shorter than 24-hours (Figure 1). This persistence of rhythmicity illustrates an
internally driven and self-sustained timekeeping system. The discovery of the self-
sustained nature of circadian rhythms is quite old and began with the study of the plant
Mimosa pudica. In the 1700s, the French astronomer d'Ortous de Mairan observed diurnal
leaf movements not only under standard light-dark conditions but also under constant
darkness. Another important feature of the circadian system is that it is dynamic and can
adapt to different external cues. For instance, the circadian clock can be synchronized, or
entrained, by exogenous zeitgebers like light or temperature. This allows the organism to
re-adjust to the new environment (Refinetti, 2015).
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Figure 1: Representative Double-Plotted Actogram of a Mouse.
Wheel-running activity of a mouse is plotted as an actogram, where horizontal lines
represent individual days and black vertical bars illustrate the activity (number of wheel
revolutions). The mouse kept in constant darkness (DD) shows a robust free-running
rhythm that is slightly shorter than 24-hours. The black and white bars at the top of the
diagram show darkness (12-h) and light (12-h), respectively. For better visualization, the
actogram is displayed twice by horizontally aligning two consecutive days. LD, light-
dark cycle; DD, constant darkness
Disruption of the circadian clock either by mutations in key circadian genes or through
misalignment between the internal clock and the environmental rhythms have a major
impact on the well-being of the organism (Bedrosian et al., 2015; Musiek and Holtzman,
2016; Reid and Zee, 2009). Familial advanced sleep phase syndrome (FASPS) is an
example of genetic mutation affecting the human molecular circadian machinery
(Mendlewicz, 2009). Circadian desynchrony, a characteristic of shift work and sleep
disruption in humans, can impair metabolic homeostasis resulting in insulin resistance
and obesity. Furthermore, desynchrony of the circadian clock results in an increased risk
of heart diseases, type 2 diabetes, and cancer (Verlande and Masri, 2019).
1.1.1 The Hierarchical Organization of the Mammalian Circadian Clock
In mammals, practically all cells harbor a cell-autonomous and self-sustained circadian
oscillator with a similar molecular composition (see below). These numerous clocks are
synchronized by a central pacemaker residing in the suprachiasmatic nucleus (SCN) of
the ventral hypothalamus (Figure 2) (Dibner et al., 2010). The SCN, a bilateral structure
of about 20,000 neurons located above the optic chiasma, receives light inputs from
specialized photoreceptors of the retina through the retinohypothalamic tract and
maintains phase coherence with the external world.
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Figure 2: The Hierarchical Organization of the Mammalian Circadian Clock.
(A and B) The central pacemaker resides in the suprachiasmatic nucleus (SCN) and
receives light inputs from specialized photoreceptors of the retina through the
retinohypothalamic tract (RHT) and maintains phase coherence with the external world.
This central pacemaker in turn synchronizes peripheral clocks located throughout the
body and maintains rhythmic behavior and physiology at the organismic level. (B)
Synchronicity is achieved through a multitude of signaling pathways. Neuronal and
hormonal outputs are direct pathways of the SCN to coordinate peripheral clocks. The
feeding-fasting rhythm on the other hand is indirectly driven through the sleep-wake
cycle, that is controlled by paracrine signals of the central pacemaker. Feeding-fasting
rhythms represent the most potent synchronization signals for peripheral organs, like the
liver. Finally, body temperature rhythms are another important signal to synchronize
peripheral clocks. These rhythms are generated by the SCN either directly through
neuronal signals or indirectly through the control of the sleep-wake cycle. The illustration
is adapted from Korf and von Gall (2013).
The SCN synchronizes the oscillators in peripheral tissues, on the one hand, through
direct systemic cues such as hormones, metabolites, temperature or the sympathetic
nervous system (Dibner et al., 2010). On the other hand, the SCN is able to synchronize
peripheral tissues through indirect zeitgebers like feeding-fasting rhythms, that are driven
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by the SCN through the sleep-wake cycle (Dibner et al., 2010; Schibler et al., 2015).
Feeding-fasting rhythms represent the most potent synchronization signals for circadian
oscillators of peripheral organs, like the liver (Plautz et al., 1997; Schibler et al., 2015).
The synchronization cues are apparently diverse in SCN and peripheral cells.
Noteworthy, the SCN is mainly unresponsive to the synchronization signals it uses to
entrain peripheral oscillators (Balsalobre et al., 2000; Buhr et al., 2010; Damiola et al.,
2000).
Surgical ablation or genetic disruption of the circadian clock in the SCN leads to loss of
phase coherence between the various peripheral tissues illustrating the essential role of
the SCN for orchestration of consistent rhythms at the organism level (Husse et al., 2011;
Moore and Eichler, 1972; Stephan and Zucker, 1972).
1.1.2 Molecular Organization of the Mammalian (Core) Circadian Clock
Although the central and peripheral oscillators show certain differences, the clocks in
these tissues are based on two interlocked transcriptional-translational feedback loops
(Figure 3). At the heart of these oscillators is the basic helix-loop-helix (bHLH) domain-
containing transcription factor brain and muscle ARNT-like protein 1 (BMAL1) (encoded
by Aryl hydrocarbon receptor nuclear translocator-like protein 1 (Arntl1). BMAL1
forms a heterodimer complex with either circadian locomotor output cycles kaput
(CLOCK) or neuronal Per-Arnt-Sim (PAS) domain protein 2 (NPAS2), two bHLH
domain-containing transcription factors (Gekakis et al., 1998; King et al., 1997; Wu and
Rastinejad, 2017). Subsequently, the complexes bind to cis-regulatory elements harboring
E-boxes of target genes such as Period (encoded by Per1, Per2, and Per3) and
Cryptochrome (encoded by Cry1 and Cry2) during the activation phase (Gekakis et al.,
1998; Kume et al., 1999; Shearman et al., 2000). PER and CRY proteins form large
heterocomplexes with over 30 additional polypeptide subunits (Aryal et al., 2017),
translocate into the nucleus, and inhibit their own expression during the repression phase
(Lee et al., 2001; Takahashi, 2017). As repression progresses, repressor complexes are
ultimately degraded by the proteasome (Gallego and Virshup, 2007; Preußner and Heyd,
2016) and a new cycle of Per and Cry transcription can start.
Chapter 1: Introduction 5
Figure 3: Molecular Organization of the Mammalian Circadian Clock.
At the heart of the circadian clock, transcription factors CLOCK and BMAL1 induce the
expression of Per1, Per2, Cry1 and Cry2 genes. PER and CRY proteins translocate into
the nucleus and repress their own transcription. Stability of the repressor proteins plays
an important role in this scenario and is regulated by the ubiquitin-proteasome system.
CLOCK-BMAL1 also induce the rhythmic expression of the nuclear receptors REV-
ERBα and REV-ERBβ, which in turn repress the transcription of Bmal1 and Nfil3 that
are driven by the two activators RORα and RORβ. The protein product of Nfil3 itself is a
repressor that counteracts the transcriptional activity of DBP and thereby drives the
rhythmic expression of Ror genes. The interplay between these three interlocked
transcriptional feedback loops drives the transcriptional output of the circadian clock.
Various combinations of these loops generate different phases of rhythmic gene
expression as illustrated by the graph (top right) showing the mRNA accumulation of
different clock genes in the liver. The same principles apply to clock-controlled output
genes (CCGs) as well where the regulatory regions of the target genes determine which
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of the three loops drives their rhythmic gene expression. AMPK, 5′ AMP-activated
protein kinase; CK1, casein kinase 1; CRE, cAMP response element; FBX, F-box protein;
RORE, ROR-binding element; SCF, SKP1–cullin–F-box protein; SRE, serum response
element; Ub, ubiquitin. The illustration is adapted from Takahashi (2017).
Recent genome-wide studies mapping the binding of core transcription factors and RNA
Polymerase II (RNA Pol II) in the mouse liver revealed the presence of at least three
distinct phases of the circadian cycle (Koike et al., 2012): (1) a transcriptionally active
phase marked by the presence of the CLOCK-BMAL1 heterodimer along with the
coactivators cAMP response element-binding protein (CREB)-binding protein (CBP) and
histone acetyltransferase p300 (p300) (2) an early repression phase during which PER1,
PER2, and CRY2 occupancy peaks and transcription declines and (3) a late repression
phase characterized by a poised but transcriptionally silent, E-box-bound CLOCK-
BMAL1-CRY1 complex (Koike et al., 2012).
In addition to generating and maintaining self-sustained circadian rhythms, the circadian
clock drives the rhythmic expression of thousands of clock-controlled output genes in
various tissues. However, only a small proportion of these genes exhibit rhythmic
expression in all tissues (Storch et al., 2002; Zhang et al., 2014). The circadian clock has
rather the function to drive tissue-specific rhythmic expression of genes involved in
various cellular processes such as metabolism (Bass and Takahashi, 2010; Green et al.,
2008; Panda, 2016), immune function (Scheiermann et al., 2013), or cell proliferation
(Gaucher et al., 2018). Transcriptome analysis of mice and a primate have shown that
more than half and more than 80 percent of all genes cycle at the mRNA level in at least
one tissue, respectively (Mure et al., 2018). Thereby, roughly 5-20 percent of genes
expressed in any particular cell or tissue undergo circadian oscillation, thus the main task
of the mammalian clock seems to be transcription control of clock target genes.
1.1.2.1 The Positive Feedback Loop
The CLOCK-BMAL1 heterodimer forms an ~750 kDa complex during the activation
phase (Aryal et al., 2017) and is believed to orchestrate some of its role as transcription
activator through recruitment of histone-modifying enzymes (DiTacchio et al., 2011;
Katada and Sassone-Corsi, 2010; Menet et al., 2014; Siepka et al., 2007), opening up the
chromatin allowing transcription to start. Involvement of additional transcription factors
and epigenetic regulation was also supported by the observation that binding of the
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CLOCK-BMAL1 complex to its cognate DNA binding elements is insufficient to induce
transcription (Etchegaray et al., 2003; Koike et al., 2012; Lee et al., 2001; Menet et al.,
2012; Ripperger and Schibler, 2006; Stratmann et al., 2012).
At the beginning of the circadian transcription cycle, CLOCK-BMAL1 heterodimer
directly interacts with the transcriptional coactivators p300 and CBP. This interaction is
believed to result in acetylation of histones surrounding E-boxes providing an accessible
chromatin state resulting in recruitment of the general transcription machinery (Curtis et
al., 2004; Etchegaray et al., 2003; Hosoda et al., 2009; Koike et al., 2012; Lee et al., 2010;
Takahata et al., 2000). CLOCK was also shown to harbor intrinsic acetyltransferase
activity and to contribute to loci specific acetylation of histones (Doi et al., 2006).
CLOCK, p300, and CBP share similar histone targets. Therefore, it was proposed that
they could function at different phases of circadian transcription activation (Papazyan et
al., 2016). CLOCK could acetylate and evict histones early in the activation phase and
p300/CBP could interact with CLOCK-BMAL1 and acetylate neighboring histones later
in activation, thereby further opening chromatin and stimulating transcription (Curtis et
al., 2004; Doi et al., 2006; Lee et al., 2010; Menet et al., 2014; Papazyan et al., 2016). It
was also reported that CLOCK could acetylate its own heterodimeric partner BMAL1 at
lysine 538 (Lys538) (Hirayama et al., 2007). CLOCK-mediated acetylation of BMAL1
is supposed to take place during the repression phase and mediate CRY1 recruitment to
BMAL1 (Hirayama et al., 2007). Another cofactor that interacts with CLOCK-BMAL1
and stimulates histone acetylation is lysine-specific demethylase 5A (KDM5A)
(DiTacchio et al., 2011). KDM5A functions as an antagonist of histone deacetylase 1
(HDAC1), thereby enhance the acetylation of histones at clock gene promoters. CLOCK-
BMAL1 does not only recruit cofactors that are involved in histone acetylation but also
recruits various isoforms of mixed-lineage leukemia (MLL) family of methyltransferases
(Katada and Sassone-Corsi, 2010; Valekunja et al., 2013), thus contributing to
transcription activation. An additional cofactor that is recruited by CLOCK-BMAL1 is
thyroid hormone receptor-associated protein-150 (TRAP150) (Lande-Diner et al., 2013).
TRAP150 was reported to link the general transcription machinery to circadian target
gene promoters by association with mediator complex subunit 1 (MED1). CLOCK-
BMAL1 heterodimer itself was also shown to function as a pioneer transcription factor
that can bind nucleosomes to facilitate rhythmic chromatin remodeling and incorporation
of the histone variant H2A.Z (Menet et al., 2014). This rhythmic chromatin opening is
believed to promote binding of the general transcription machinery and of additional
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transcription factors. Thus, the CLOCK-BMAL1 heterodimer is clearly involved in RNA
polymerase II (RNA Pol II) recruitment and initiation (Koike et al., 2012; Le Martelot et
al., 2012). However, further steps such as promoter proximal pausing, pause release, and
productive elongation were proposed also to play a role in clock gene regulation (for
details about transcription cycle, see below) (Takahashi, 2017; Westermark, 2016; Zhu et
al., 2018).
1.1.2.2 The Negative Feedback Loop
Repressive complexes containing PER and CRY proteins are driving the negative
feedback loop of the circadian clock. The stability and subcellular localization of these
complexes are essential factors to maintain precision and set the 24-h period length of the
circadian clock (Busino et al., 2007; Eide et al., 2005; Godinho et al., 2007; Hirano et al.,
2013; Hirota et al., 2008; Isojima et al., 2009; Lamia et al., 2009; Lee et al., 2009; Partch
et al., 2006; Reischl et al., 2007; Shirogane et al., 2005; Siepka et al., 2007; Yoo et al.,
2013). Modulation of the balance between kinases, phosphatases, and ubiquitin E3 ligases
that post-translationally modify the PER and CRY proteins, either by gene mutations or
pharmacological inhibition, generates periods ranging from ~ 20 to 44 hours (Chen et al.,
2012; Hirota et al., 2010; Toh et al., 2001; Xu et al., 2005). Thus, post-transcriptional
regulation of the repressor complexes represents a key element of the negative feedback
loop that helps to establish the essential delays in feedback regulation.
Genome-wide analysis of the core circadian regulators revealed a well-orchestrated
chromatin association of circadian activators and repressors in the course of the circadian
day (Koike et al., 2012; Menet et al., 2012; Rey et al., 2011). It was found that at the onset
of the circadian cycle (late night/early morning) CRY1 is associated with chromatin-
bound CLOCK-BMAL1-RNA Pol II complexes without PER and is implicated in
preventing E-box-mediated transcription. The existence of such ‘late repressive complex’
is supported by the observation that PER proteins are negligible for CRY1-mediated on
DNA repression of CLOCK-BMAL1 transcriptional activation (Chiou et al., 2016; Ye et
al., 2011, 2014) and is consistent with the unique ability of CRY1 to drive rhythms in
minimal cellular oscillators (Khan et al., 2012; Liu et al., 2007; Ukai-Tadenuma et al.,
2011). The prominent role of CRY1 is also reflected in the fact that CRY1 is more
essential than CRY2 for rhythm generation and that CRY2 is a weaker repressor of the
CLOCK-BMAL1 heterodimer (Rosensweig and Green, 2018). Upon degradation of
chromatin-associated CRY1, coactivators are recruited followed by Per and Cry
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transcription. During the early repression phase of the circadian cycle (early evening),
newly synthesized CRY2 and PER repressors associate with CLOCK-BMAL1, thereby
shutting down E-box-mediated transcription. However, the mechanism of PER-mediated
repression of the ‘early repressive complex’ seems to be different to that of CRY1 and
relies on attenuation of CLOCK-BMAL1 binding to the DNA (Chiou et al., 2016; Ye et
al., 2014). The role of PER proteins was proposed to be that of scaffolding proteins that
assemble a stable and several megadaltons big repressive complex (Aryal et al., 2017;
Kim et al., 2015; Rosensweig and Green, 2018). Biochemical analysis revealed that at
least 25 additional protein components are part of this complex that are capable to give
rise to transcriptional termination and epigenetic rearrangement at the transcription start
sites of clock-controlled genes (Brown et al., 2005; Duong and Weitz, 2014; Duong et
al., 2011; Kim et al., 2014; Padmanabhan et al., 2012). One of the components is the Mi-
2–nucleosome remodeling and deacetylase (NuRD) transcriptional co-repressor with both
ATP-dependent chromatin remodeling and histone deacetylase activity (Kim et al., 2014).
Other components are the transcriptional repressor complex SWI-independent-3 (SIN3)–
histone deacetylase (HDAC) and the histone methyltransferase complex heterochromatin
protein 1 gamma (HP1γ)–suppressor of variegation 3-9 homolog (SUV39H) that
contribute to chromatin condensation (Duong and Weitz, 2014; Duong et al., 2011). Apart
from chromatin modifiers the repressive complex also recruits the helicases DEAD-box
helicase 5 (DDX5), DExH-box helicase 9 (DHX9), and senataxin (SETX) to termination
sites on clock-controlled genes, where they prevent transcriptional termination
(Padmanabhan et al., 2012).
Not only the circadian activators and repressors show temporally restricted chromatin
associations but also RNA Pol II illustrates a rhythmic abundance at promoters and gene
bodies of rhythmically expressed genes (Koike et al., 2012; Le Martelot et al., 2012).
Thus, RNA Pol II recruitment and initiation are obviously under circadian control. RNA
Pol II pausing seems to be another step of the transcription cycle (for more information
see below) that is controlled by the clock. Rhythmic accumulation of Ser5
phosphorylation of RNA Pol II during the late CRY1-containing repression phase
indicates that RNA Pol II is recruited to circadian promoters but is transcriptionally
inactive (Koike et al., 2012) and is waiting for an additional regulatory step to be released.
Thus, binding of CRY1 to CLOCK-BMAL1 may prevent productive transcription.
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1.1.3 The Transcriptional Regulation of Circadian Genes
Besides the Per and Cry genes, the CLOCK-BMAL1 transcription factor complex also
drives the expression of the reverse erythroblastosis virus-α, -β (Rev-Erbα, Rev-Erbβ)
genes (encoded by nuclear receptor subfamily 1, group D, member-1, -2 (Nr1d1 and
Nr1d2)) (Preitner et al., 2002; Sato et al., 2006) (Figure 3). The protein products of these
genes compete at retinoic acid receptor-related orphan receptor (ROR)-binding elements
(ROREs) with the transcription activators RORα, RORβ, and RORγ and thereby repress
transcription of core lock genes, such as Bmal1, Npas2, and Clock (Guillaumond et al.,
2005; Takeda et al., 2012). The inhibitory function of REV-ERBα and REV-ERBβ is not
just accomplished by restricting the access of ROR activators to target gene promoters.
In addition, REV-ERBs recruit nuclear receptor co-repressor 1 (NCoR) and histone
deacetylase 3 (HDAC3) to target gene promoters and establish a repressive chromatin
state for long-term repression (Feng et al., 2011). The CLOCK-BMAL1-driven diurnal
expression of Rev-Erbα and Rev-Erbβ is essential for the maintenance of robust circadian
expression of this interlocked accessory loop (Papazyan et al., 2016). A third E-box-
driven transcriptional loop involves the proline- and acidic amino acid-rich basic leucine
zipper (PAR-bZip) transcription factors such as D-site albumin promoter binding protein
(DBP), thyrotroph embryonic factor (TEF), and hepatic leukemia factor (HLF)
(Takahashi, 2017) (Figure 3). These proteins bind to D-box elements, present in the
promoters of clock output genes, rather than the core clock genes and show high
functional redundancy (Gachon et al., 2004). Transcriptional activity of these factors is
repressed by nuclear factor, interleukin-3-regulated (NFIL3) also known as E4BP4, that
is driven by the REV-ERB loop (Gachon et al., 2004; Mitsui et al., 2001). In summary,
these three interlocked transcriptional feedback loops generate rhythmic expression with
a wide range of phases (Ueda et al., 2005). Combination of the three cis-elements (E-
boxes, ROREs, and D-boxes) in the promoters of clock genes coordinate clock
transcription factor binding and gene transcription (Figure 3). For example, Cry1
expression, which shows delayed accumulation relative to other direct CLOCK-BMAL1
target genes, is regulated by both E-boxes and ROREs cis-regulatory elements (Ukai-
Tadenuma et al., 2011) and might explain its time restricted chromatin abundance (see
above).
Although the composition of the circadian oscillator is quite similar throughout the body,
there are several interesting differences in how they function in the SCN and peripheral
tissues, such as the liver. In the SCN, CLOCK and BMAL1 are absolutely essential for
Chapter 1: Introduction 11
the rhythmic expression of the repressors Per1 and Per2 (Bunger et al., 2000; Schibler et
al., 2015). However, in mice livers Per1 and Per2 still show rhythmic expression in the
absence of CLOCK and BMAL1, as long as they receive direct or indirect systemic cues
from the SCN (DeBruyne et al., 2006; Kornmann et al., 2007a, 2007b). Cry1 and Cry2
transcripts lose their rhythmic expression in the same livers of CLOCK-deficient animals
but are highly upregulated, which is in contrast to the function of CLOCK as a
transcriptional activator (DeBruyne et al., 2006). On the contrary, expression of the two
CLOCK-BMAL1 target genes Dbp and Rev-Erbα, that drive the rhythmic output of the
interlocked accessary loops, is as expected strongly downregulated in both CLOCK- and
BMAL1-deficient livers (Bunger et al., 2000; Damiola et al., 2000; DeBruyne et al., 2006;
Kornmann et al., 2007b). Thus, the main function of CLOCK-BMAL1 in peripheral
tissues is likely to control rhythmic expression of the two interlocked accessory loops,
rather than that of Per and Cry genes (Schibler et al., 2015). This is in contrast to the
function of CLOCK-BMAL1 in the SCN, where the heterodimer strictly regulates Per
and Cry gene transcription and thereby produces self-sustained cycles of clock gene
expression. Thus, analysis of core clock gene transcription in a tissue context are rather
complex, as expression can be orchestrated by both the local oscillator and systemic cues
(Figure 2). Ex vivo experiments with cells and tissue performed under steady state
conditions (in the absence of rhythmic systemic cues) allowed a direct and simplified
investigation of CLOCK-BMAL1 dependent transcription control (DeBruyne et al.,
2007; Kornmann et al., 2007b). In this context, the E-box controlled regulators of the
accessary loops represent robust readouts of the transcriptional activity of the CLOCK-
BMAL1 heterodimer independent of the cell context.
1.2 The RNA Polymerase II Transcription Cycle
As in the case of the circadian oscillator, the precise interplay between positive and
negative regulatory factors determines the overall rate of transcription by RNA Pol II.
The regulation of the eukaryotic transcription cycle occurs at multiple steps, starting with
initiation, followed by elongation, and subsequently termination with release of RNA Pol
II and the nascent transcript from the DNA template (Figure 4) (Core and Adelman, 2019;
Jonkers and Lis, 2015; Liu et al., 2015; Porrua and Libri, 2015; Sainsbury et al., 2015).
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Figure 4: The RNA Polymerase II Transcription Cycle
Regulation of the transcription cycle at the transcription start sites (TSSs) takes place
mainly at the level of promoter recruitment and release of RNA Pol II from promoter-
proximal pause sites. These two steps show the highest variability in terms of rate. Less
variable and less regulated steps of the transcription are transcription entry to the pause
site and transcription termination from the pause site. The illustration is adapted from
Jonkers and Lis (2015).
The large subunit of RNA Pol II contains a carboxy-terminal domain (CTD) that is
subjected to a large number of posttranslational modifications throughout the
transcription cycle and acts as a binding platform for a multitude of transcription-
associated factors involved in distinct stages of the transcription cycle. In addition, CTD
serves as a scaffold for RNA maturation factors that process the RNA co-transcriptionally
(Harlen and Churchman, 2017). The CTD of RNA Pol II is composed of 52 tandem
heptapeptide repeats in mammals with a consensus sequence of Tyr1-Ser2-Pro3-Thr4-
Ser5-Pro6-Ser7 (Eick and Geyer, 2013; Harlen and Churchman, 2017). Phosphorylation
of the serine residues at specific stages of the transcription cycle play an essential role in
driving gene transcription, which will be discussed in more detail below (Figure 5).
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Figure 5: Transcription Regulation by the RNA Pol II CTD
(A) Chromatin occupancy profiles of phosphorylated residues of RNA Pol II CTD across
protein-coding genes. (B) The distinct stages of the transcription cycle are accompanied
by changes in the phosphorylation state of the CTD. (1) Hypoacetylated RNA Pol II is
recruited to the promoter. After phosphorylation of Ser5 of the CTD by the CDK7 subunit
of THIIH, Pol II escapes from the promoter. (2) RNA Pol II is paused downstream of
TSSs, through interaction with NELF and DSIF, and is highly phosphorylated at Ser5 and
Ser7 of the CTD. Recruitment of P-TEFb stimulates the transition into productive
transcription elongation. P-TEFb phosphorylates NELF, DSIF and Ser2 of the CTD
resulting in the release of NELF and productive transcription. (3) Phosphorylation of Ser2
promotes the recruitment of a multitude of transcription elongation, chromatin-
modifying, and RNA-processing factors allowing co-transcriptional processes. As the
RNA Pol II progresses toward the 3’ end of the gene, dephosphorylation of Ser5 and Ser7
is catalyzed by phosphatases. (4) RNA Pol II reaches the polyadenylation site (PAS) and
transitions from elongation to termination. Phosphorylation of Ser2 and Thr4 promotes
the recruitment of cleavage, polyadenylation, and termination factors that release RNA
Pol II from the DNA. The illustration is adapted from Harlen and Churchman (2017).
1.2.1 Transcription Initiation and Promoter Clearance
The first step of the transcription cycle is the formation of the preinitiation complex (PIC)
at the promotor regions of genes. The stepwise PIC assembly starts with the binding of
TFIID (transcription factor IID) or similar complexes to core promoter sequences.
Subsequently, other general transcription factors (GTFs) like TFIIH (transcription factor
IIH) and TFIIE (transcription factor IIE) together with the RNA Pol II are recruited to
form the PIC. The ATP-dependent helicase activity of TFIIH leads to unwinding of the
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promoter DNA and formation of the transcriptionally competent open complex. This step
provides access for RNA Pol II to the template strand and enables RNA synthesis. The
emerging transcript enhances the stability of the transcribing complex and leads to
promoter escape (Sainsbury et al., 2015).
Formation of PIC stimulates the kinase activity of the CDK7 subunit of THIIH, which
then phosphorylates Ser5 and Ser7 of the CTD. Phosphorylation of Ser5 leads to the
recruitment of RNA 5’ capping enzymes that add a 7-methylguanosine (m7G) cap to the
5’ end of nascent transcript. This protects the RNA from degradation by nuclear
exoribonucleases and promotes their transport to the cytoplasm (Eick and Geyer, 2013;
Harlen and Churchman, 2017) (Figure 5b – 1).
1.2.2 Transcription Elongation
For a variety of genes, once RNA Pol II escapes the transcription start site (TSS), the
elongating polymerase pauses 30-100 nucleotides downstream of the TSS and then
experiences promoter-proximal pausing. Promoter-proximal pausing is believed to keep
the promoter nucleosome-free and accessible to transcription factors (Gilchrist et al.,
2010).
The pause release of RNA Pol II and the transition to productive elongation requires the
activity of the positive transcription elongation factor b (P-TEFb) complex, composed of
T-type cyclins and cyclin-dependent kinase 9 (CDK9) (Jonkers and Lis, 2015; Liu et al.,
2015). P-TEFb phosphorylates the pausing factors negative elongation factor (NELF) and
DRB sensitivity inducing factor (DSIF). Upon phosphorylation, NELF is evicted from
RNA Pol II and DSIF becomes a positive elongation factor. Accordingly, blocking
efficient pause release by inhibition of CDK9 with flavopiridol augments promoter-
proximal pausing and downregulates global gene transcription (Jonkers et al., 2014; Rahl
et al., 2010). Thus, promoter-proximal pausing seems to occur for nearly all RNA Pol II-
mediated transcription independent of whether paused RNA Pol II accumulates at the
promoter-proximal sites or not. This checkpoint is believed to be important for the
assembly of the elongation complex and for the recruitment of factors essential for
elongation (Jonkers and Lis, 2015; Liu et al., 2015). Therefore, the release of RNA Pol II
from promoter-proximal pausing sites serves as a well-recognized and rate-limiting step
allowing for strong, rapid, and synchronous expression of genes (Boettiger and Levine,
2009; Gilchrist et al., 2012; Lagha et al., 2013; Lin et al., 2011; Liu et al., 2015).
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CDK9 also phosphorylates the CTD of RNA Pol II at Ser2 position and allows the
transition to productive elongation. Phosphorylation of Ser2 promotes recruitment of
transcription elongation factors, histone modifiers, chromatin remodelers, and the
splicing machinery. As the RNA Pol II progresses toward the 3’ end of the gene,
dephosphorylation of Ser5 of the CTD is catalyzed by the phosphatase RNA Pol II subunit
A C-terminal domain phosphatase (SSU72) (Eick and Geyer, 2013; Harlen and
Churchman, 2017) (Figure 5b – 2; 3).
1.2.2.1 Recruitment of P-TEFb to Promoters
P-TEFb is rectuited to promoter-proximal sites through interaction with specific
transcription factors and other proteins like bromodomain-containing protein 4 (BRD4)
and super elongation complex (SEC) (Core and Adelman, 2019; Jonkers and Lis, 2015).
BRD4 is a member of the BET (bromo-domain and extra terminal domain) protein family
and harbors two amino-terminal bromodomains (BD1 and BD2), an extra-terminal
domain and a carboxy-terminal P-TEFb interaction domain (PID) (Shi and Vakoc, 2014).
Bromodomains are responsible to recognize acetylated lysine residues on histones and
non-histone proteins. Complex formation between BRD4 and P-TEFb prevents P-TEFb
from association with a ribonucleoprotein complex, 7SK/ hexamethylene bis-acetamide
inducible protein 1 (HEXIM) that sequesters P-TEFb in an inactive state (Core and
Adelman, 2019; Jonkers and Lis, 2015).
Among the non-histone proteins, BRD4 was reported to interact with several specifically
acetylated transcription factors. An example is the heterodimeric transcription factor
complex twist family bHLH transcription factor 1 (TWIST1) - spermatogenic leucine
zipper protein 1 (SPZ1) that uses BRD4 as a coactivator. Di-acetylation of SPZ1 at
Lys369 and Lys374, and of TWIST1 at Lys73 and Lys76 leads to BRD4 recruitment and
P-TEFb-mediated transcription activation (Shi et al., 2014; Wang et al., 2019). Another
transcription factor whose acetylation facilitates BRD4 recruitment is the RELA/p65
subunit of nuclear factor kappa light chain gene enhancer in B cells (NF-κB). Lys310
acetylation of RELA/p65 leads to the recruitment of BRD4 and P-TEFb to NF-κB target
genes and their transcriptional activation (Huang et al., 2009; Zou et al., 2014).
Several small molecule inhibitors with high affinity towards BRD4 have been recently
reported (Wang and Filippakopoulos, 2015). These inhibitors occupy the bromodomains
and compete with acetylated lysine residues on histones and non-histone proteins. This,
in turn, displaces BRD4 from chromatin and prevents its function in transcription
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activation. In accordance with this, treatment of cells with JQ1 disrupted the interaction
between BRD4 and acetylated TWIST or acetylated RELA/p65, coinciding with the
repression of TWIST- or NF-κB-induced transcriptional response (Shi et al., 2014; Zou
et al., 2014).
Thus, BRD4 protein is a key player in the regulation of productive transcription
elongation and is important for rapid and synchronous transcriptional induction, as
observed in response to signal-dependent activation or during exit from mitosis (Shi and
Vakoc, 2014). By implication, acetyltransferases that acetylate BRD4 binding partners
would play an important role in regulating RNA Pol II pause release. Of particular
relevance for the present study is the lysine acetyltransferase 60 kDa Tat-interactive
protein/K(lysine) acetyltransferase 5 (TIP60/KAT5). TIP60 is an essential protein (Hu et
al., 2009), which is recruited to active promoters (Ravens et al., 2015) and was proposed
to play a role in early steps of transcription elongation in mammals and flies (Kusch et
al., 2004; Ravens et al., 2015; Shi et al., 2014; Wang et al., 2019).
1.2.3 Transcription Termination and Reinitiation
Once RNA Pol II transcribes the polyadenylation site, cleavage- and polyadenylation
factors recognize this sequence element in the emerging transcript, and promote the
cleavage and release of the nascent transcript. Ser2-phosphorylated CTD of RNA Pol II
plays an essential role in this process and acts as a scaffold for the recruitment of these
termination factors (Eick and Geyer, 2013; Porrua and Libri, 2015) (Figure 5b – 4).
The released RNA Pol II can enter subsequent a new round of transcription, however, it
needs to go back to its original hypophosphorylated state. Several phosphatases were
reported to catalyze the dephosphorylation of RNA Pol II and are essential for the
recycling of RNA Pol II for another transcription cycle (Porrua and Libri, 2015; Shandilya
and Roberts, 2012). Some of the general transcription factors remain bound with the
promoter after RNA Pol II escapes from the PIC. This promoter associated GTFs act as a
binding platform that allows reinitiation of RNA Pol II during successive rounds of
transcription (Shandilya and Roberts, 2012). Factors associated with transcription
termination also mediate formation of gene loops that brings the promoter bound GTFs
and the 3’-ends of genes in close proximity and support efficient recycling and reinitition
of RNA Pol II on the same DNA template (Hampsey et al., 2011).
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1.2.4 Role of TIP60 in Transcription Control
TIP60, is a member of the Moz, Ybf2/Sas3, Sas2, Tip60 (MYST) family of histone
acetyltransferases and the catalytic subunit of the evolutionarily highly conserved
nucleosome acetyltransferase of histone 4 (NuA4) complex (Jacquet et al., 2016). This
complex, also known as TIP60 complex in mammals, is a large multiprotein complex
consisting of at least 16 subunits (Figure 6B) (Doyon and Côté, 2004). Two distinct
catalytic mechanisms have been proposed for TIP60 (Berndsen et al., 2007; Decker et al.,
2008). The acetyltransferase either employs a ternary complex mechanism, where Glu403
serves as a general base and abstracts a proton from the substrate lysine (Berndsen et al.,
2007), or a ping-pong mechanism via an acetyl-cysteine (Cys369) intermediate (Decker
et al., 2008) (Figure 6B).
Figure 6: The Acetyltransferase TIP60 is Part of a Multiprotein Complex.
(A) Graphic showing the TIP60 complex composition. The illustration is adapted from
Jacquet et al. (2016). (B) Close-up view of the active site of TIP60 co-crystallized with
Acetyl-Coenzyme A (Acetyl-CoA). Catalytic residues are labeled. (PDB: 2OU2)
TIP60 is involved in a multitude of cellular processes such as DNA damage response,
chromatin remodeling, apoptosis, and transcription regulation (Ghobashi and Kamel,
2018). In transcription, TIP60 acts as a coactivator through acetylation of histone and
non-histone proteins and associates with a growing number of transcription factors
(Ghobashi and Kamel, 2018; Judes et al., 2015). For example, TIP60 is known to acetylate
the hinge region of androgen receptor (AR) augmenting its hormone-dependent
transactivation potential (Clinckemalie et al., 2012). TIP60 also enhances transcriptional
activity of NF-κB by physical interaction with the RELA/p65 subunit of NF-κB and
maintaining Lys310 RELA/p65 acetylation (Kim et al., 2012). This leads to the
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recruitment of BRD4-P-TEFb and stimulates transcription of NF-κB target genes (Huang
et al., 2009; Zou et al., 2014). Another substrate of TIP60 is the transcription factor
myelocytomatosis oncogene (c-MYC). Acetylation of c-MYC increases its protein
stability (Patel et al., 2004). Furthermore, c-MYC recruits the TIP60 complex to c-MYC
target genes, promoting histone H4 acetylation and target gene transcription (Frank et al.,
2003). Similarly, E2F transcription factor 1 (E2F1) recruits the TIP60 complex on its
target gene promoters in late G1 phase resulting in histone H4 acetylation and subsequent
transcription (Taubert et al., 2004). Moreover, TIP60 coactivates the transcription factor
C/EBPα (CCAAT/enhancer binding protein α) by physical interaction and acetylation of
histones at C/EBPα-target genes (Bararia et al., 2008). The best-studied transcription
factor that is acetylated by TIP60 is tumor protein p53 (p53). TIP60 acetylates p53 at
Lys120 within the DNA binding domain in response to DNA damage (Sykes et al., 2006;
Tang et al., 2006). TIP60-mediated acetylation of p53 promotes expression of pro-
apoptotic genes and initiates an apoptotic pathway to eliminate DNA-damaged cells
(Charvet et al., 2011; Tang et al., 2006). Thus, TIP60 plays an important role in the
decision between cell cycle arrest and apoptosis and maintains genome integrity. Two
other transcription factors that are acetylated by TIP60 is TWIST1 and its heterodimeric
partner SPZ1. TIP60 mediates di-acetylation of SPZ1 at Lys369 and Lys374, and of
TWIST1 at Lys73 and Lys76, which are required for SPZ1-TWIST1 complex formation
and BRD4 recruitment, thus enhancing RNA Pol II dependent transcription (Shi et al.,
2014; Wang et al., 2019).
1.3 Objectives
Many physiological processes exhibit circadian rhythms driven by cellular clocks
composed of interlinked activating and repressing elements. The far-reaching influence
of circadian rhythmicity is highlighted by the fact that in each tissue ~10 % of the
transcriptome is under the control of the circadian clock (Zhang et al., 2014) and that
disruption of circadian rhythms is tied to the development of various diseases including
metabolic disorders and cancer (Bedrosian et al., 2015; Musiek and Holtzman, 2016).
Although significant progress was made in understanding the molecular principles of this
oscillator and the field was even awarded with the Nobel Prize, still many open questions
remain. One of them is: How does the CLOCK-BMAL1 heterodimer recruit the
transcriptional machinery and thereby activate rhythmic gene transcription. Binding of
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CLOCK-BMAL1 to E-box elements alone is insufficient to induce transcription
(Etchegaray et al., 2003; Koike et al., 2012; Lee et al., 2001; Menet et al., 2012; Ripperger
and Schibler, 2006; Stratmann et al., 2012). Thus, additional factors are involved in the
process of transcriptional activation of clock-controlled genes. In order to shed some light
on this issue, a variety of different biochemical approaches are applied to identify several
new components that regulate this process. In the center is a posttranslational
modification of one of the heterodimeric partners that links CLOCK-BMAL1 with the
transcriptional machinery. Subsequently, behavior analysis of mice that lack the enzyme
mediating the posttranslational modification are presented to support the proposed model
of transcriptional activation of E-box controlled clock genes.
Although CRY proteins were identified as key negative regulators of the mammalian
circadian clock almost two decades ago (van der Horst et al., 1999), the mechanism by
which the repressors fulfill their function is still not known. To fill up this gap, the
repressive function of CRY-proteins is examined in the context of the new proposed
model of transcriptional activation. To test this hypothesis interactions of CLOCK-
BMAL1 with the new identified components at clock gene promoters using CRY gain-
of-function and CRY loss-of-function cell models are presented. Finally, to converge the
positive and negative limb of the circadian cycle changes in the interaction of the different
components between each other and with clock gene promoters are presented over a
course of 24-hours.
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Chapter 2:  Material and Methods
Parts of this thesis have been published in:
Petkau N, Budak H, Zhou X, Oster H, Eichele G. 2019. Acetylation of BMAL1 by
TIP60 controls BRD4-P-TEFb recruitment to circadian promoters. Elife 8.
2.1 Animal Experiments
2.1.1 Animal Housing and Breeding
Animal experiments were carried out in compliance with the German Animal Welfare act
(Tierschutzgesetz) and ethically approved and licensed by the Office for Consumer
Protection and Food Safety of the State of Lower Saxony (Niedersächsisches Landesamt
für Verbraucherschutz und Lebensmittelsicherheit). Mice were kept in transparent,
individually ventilated cages under a 12 hours light and 12 hours dark (12:12 LD) cycle
in a temperature- and humidity-controlled room at 21 °C and 55%, respectively. Mice
were fed standard chow ad libitum with free access to water.
2.1.2 Tissue Collection
Tissue collection was performed under constant darkness conditions (DD). Single-housed
male mice were entrained to 12:12 LD cycle for at least 10 days and released into DD.
For radioactive in situ hybridization analysis, mice were sacrificed at four time points on
the second day in DD and brains were collected and frozen in O.C.T. medium (Tissue-
Tek). Tissue collection was mainly conducted by Dr. Harun Budak. For
immunohistochemistry and TUNEL analysis brains were collected 42 hours after release
into darkness and frozen in O.C.T. medium. Liver samples were collected at 6-hour
intervals on the second day in DD and flash frozen in liquid nitrogen and stored at
-80 °C.
2.1.3 Wheel-Running Analysis
Wheel-running experiments were conducted as described previously (Jud et al., 2005).
Male mice at the age of 2 to 6 months were single housed in cages equipped with a running
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wheel and revolutions of the wheel were detected via a magnetic switch connected to a
computer system. Lighting conditions in the cages were adjusted by an external control
device. Standard chow and water were provided ad libitum throughout the duration of the
experiment. Wheel-running experiments were predominantly performed by Dr. Harun
Budak.
Mice were entrained to an 12:12 LD cycle for at least 2 weeks and released into constant
darkness. Free-running period (τ) of locomotor activity was calculated using χ2-
periodogram analysis by the ClockLab analysis software plug-in (Actimetrics) for
MatLab (MathWorks).
2.2 Experimental Models
Cell lines and organisms used as experimental models in this study are listed in Table 1
and Table 2, respectively.
Table 1: Cell Lines
Resource Source
NIH 3T3 Bmal1-LUC (Nagoshi et al., 2004)
NIH 3T3 Bmal1-LUC; Bmal1K538R This study
Tip60fl/- MEFs This study
Tip60fl/- Bmal1-LUC MEFs This study
Tip60fl/- Bmal1-LUC; Tip60-V5 MEFs This study
Tip60fl/- Bmal1-LUC; Tip60 C369A;E403Q-V5 MEFs This study
Tip60-l/- Bmal1-LUC; Tip60-V5 MEFs This study
Cry1+/+; Cry2+/+ fibroblasts (Gauger and Sancar, 2005)
Cry1-/-; Cry2-/- fibroblasts (Gauger and Sancar, 2005)
Clock+/+ MEFs (Spengler et al., 2009)
Clock-/- MEFs (Spengler et al., 2009)
Bmal1+/+ MEFs (Spengler et al., 2009)
Bmal1-/- MEFs (Spengler et al., 2009)
HEK239T ATCC - CRL-3216
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Table 2: Organisms/Strains
Resource Source
Rosa26Flpe/Flpe: Gt(ROSA)26Sortm1(FLP1)Dym JAX: 003946
CMV-Cre: Tg(CMV-cre)1Cgn JAX: 006054
Syt10Cre/Cre (Husse et al., 2011)
Syt10Cre/+ (Husse et al., 2011)
Tip60fl/fl This study
Tip60fl/- This study
Tip60+/- This study
Syt10Cre/+ Tip60fll- This study
Syt10Cre/Cre Tip60fll- This study
LSL-Tip60-FLAG: Tg(loxP-STOP-loxP-Tip60-3xFLAG) This study
Tip60fl/fl LSL-Tip60-FLAG This study
AlbCre: Speer6-ps1Tg(Alb-cre)21Mgn JAX: 003574
Tip60fl/fl LSL-Tip60-FLAG AlbCre This study
Tip60fl/fl AlbCre This study
2.2.1 Tip60 Targeting Vector and Generation of Experimental Animals
The Tip60fl/fl mouse line was generated by Dr. Xunlei Zhou using the following
procedure: Bacteria (Strain EL350) and plasmids (pL451 and pL452) used for
recombineering were obtained from the NCI (Biological Resources Branch). A 15.7-kb
fragment of Tip60 genomic DNA was cloned from a BAC clone (bMQ-331N14, Sanger
Institute) into a targeting vector carrying a Pol2-DTA cassette for negative selection. The
first loxP site was inserted 637 bp upstream of the Tip60 ATG. The second loxP site
together with a FRT-flanked PGK-neo cassette was inserted 3,065 bp downstream of the
ATG. The 5’ end of the homologous arm of the targeting vector was 4.5 kb and the 3’
end of the homologous arm was 7.6 kb. ES cell targeting and generation of Tip60fl/+
founder mice was commissioned to PolyGene Transgenics (Switzerland). The FRT-
flanked PGK-neo selection cassette was removed by crossing mice with a Flippase-
expressing deleter line (Henrich et al., 2000). Targeting strategy for the Tip60 locus is
provided in Figure 7.
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Figure 7: Generation of Tip60-deficient Mice.
(A) Targeting strategy for the Tip60 locus. Tip60 wildtype allele, targeting vector,
targeted allele, floxed allele after removal of the PGK-Neo cassette, and the mutant Tip60
allele created by Cre-mediated recombination are shown. LoxP (black triangle) and FRT
(open triangle) sites are marked. The arrows indicate the position of diagnostic primers
P1-P3 (see Table 7). (B) PCR genotyping of Tip60 alleles. The wildtype allele produces
a 331-bp amplicon (primers P1, P2) while the floxed allele produces a 429-bp amplicon
(P1, P2). Deletion of the LoxP-flanked region of the Tip60 locus leads to a 487-bp
fragment (P1, P3).
Mice deficient for TIP60 in the SCN were generated by Dr. Harun Budak and Dr. Xunlei
Zhou. To generate these animals for locomotor activity recording, Tip60fl/fl mice were
crossed to a Syt10Cre driver mouse line resulting in Cre-mediated deletion of TIP60
predominately in the SCN (Husse et al., 2011). To generate Tip60fl/- mice for subsequent
MEF isolation, Tip60fl/fl mice were crossed to a ubiquitous CMVCre driver mouse line
(Schwenk et al., 1995) to generate Tip60+/- heterozygotes which were then used for
breeding with Tip60fl/fl mice to obtain Tip60fl/- offspring. To generate animals for
biochemical analysis, Tip60fl/fl mice were crossed to a AlbCre driver mouse line resulting
in TIP60 deletion exclusively in the liver (Postic et al., 1999). For all types of studies,
mice were previously backcrossed to a C57BL/6 background for at least 10 generations.
2.2.2 Generation of Bmal1K538R Mutant Cells
Bmal1K538 mutant cell lines were generated using CRISPR/Cas9-based genome editing.
Fibroblasts stably expressing a clock-driven luciferase reporter (Bmal1-LUC) (Nagoshi
et al., 2004) were co-transfected with an all-in-one plasmid pSpCas9(BB)-2A-Puro
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(PX459) harboring CAS9, puromycin-resistance gene, and guide RNA (sgRNA), and a
single-stranded oligodeoxynucleotide (ssODN) template comprising the point mutation.
The sequence of ssODN was 5’-GCTCCAGCCCATTGAACATCACGA
GTACGCCTCCCCCTGATGCCTCTTCTCCAGGcGGacAGAAGGTAAGACTGATG
ATTCTTAGCCTAAGCTAGAGAACCTCTTGCCCAAGATCTGAAA-3’ (lowercase
letters indicate the mutation sites). The sgRNA was designed using the online tool
(http://crispr.mit.edu/). The target sequence of sgRNA was 5’-
GGTCCTCCGTTCTTCCATTGTA-3’ (PAM sequence is underlined). Transfected cells
were selected with 1 µg/ml puromycin (Alfa Aesar) for two days and clonal cell lines
were isolated by limiting dilution. Genomic DNA of these clones was extracted and
subjected to sequencing. Targeting strategy for the Bmal1 locus is provided in Figure 8.
Figure 8: CRISPR/Cas9-mediated Generation of BMAL1K538R Mutant Cells.
Schematic representation of the gene targeting strategy for generating BMAL1K538R
mutant cells using the CRISPR/Cas9 system. The gRNA-targeting sequence is underlined
and the PAM sequence is indicated in red. The oligonucleotide donor (120 bp) is shown
below the targeted site, with the Lys-to-Arg substitution indicated in red. Silent point
mutations were introduced for the two adjacent Gly to prevent cutting of the donor DNA
or re-cutting of the genome after homology-directed recombination (shown in red). The
arrows indicate the position of primers used for sequencing (see Table 7).
Exon 18Bmal1
Genome
sequence
5´...TTCTCCAGGAGGCAAGAAGGTAAGCATGATG...3´
3´...AAGAGGTCCTCCGTTCTTCCATTCGTACTAC...5´
ssDNA
template
HDR
5´-GCTCCA...CCAGGCGGAAGGAAG...CCTAGA-3´
Left homology
arm (53 bp)
Right homology
arm (58 bp)
Gly Gly Arg
(9bp)
Gly Gly Lys
P1
P2
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2.2.3 Generation of loxP-STOP-loxP-Tip60-3xFLAG BAC and Experimental
Animals
The loxP-STOP-loxP-Tip60-3xFLAG BAC construct was generated by PolyGene
Transgenics (Switzerland). A BAC clone (RP23-156A18, Children's Hospital Oakland
Research Institute) containing the complete Tip60 locus was first modified by introducing
a triple FLAG-tag at the C-terminus of Tip60 gene. Subsequently, a loxP-flanked STOP
cassette was introduced downstream of the first exon. The construct was injected into
pronuclei of fertilized eggs, and transgenic founders were screened for loxP-flanked
STOP cassette and 3xFLAG integration. The final transgene construct is shown in Figure
9.
Figure 9: The loxP-STOP-loxP-Tip60-3xFLAG BAC Transgene.
The floxed transgene and the mutant transgene created by Cre-mediated recombination
are shown. LoxP (black triangle) and FRT (open triangle) sites are marked. The arrows
indicate the position of diagnostic primers STOP P1-P3 and FLAG P1-P2 (see Table 7).
To generate liver specific Tip60-3xFLAG mice for biochemical analysis, transgenic loxP-
STOP-loxP-Tip60-3xFLAG (LSL-Tip60-FLAG)) mice were first crossed to Tip60fl/fl mice.
Transgene-positive Tip60fl/fl mice were then used for breeding with a AlbCre driver mouse
line (Postic et al., 1999) resulting in Cre-mediated deletion of TIP60 and the STOP
cassette in the liver. Thus, endogenous TIP60 was replaced by a FLAG-tagged version of
TIP60 exclusively in the liver.
2.3 Immunohistochemistry
Cryo-sectioning was carried out by technical staff and coronal sections of 10 µm were
produced. Cryo-sections through the SCN were fixed with 4% paraformaldehyde for 15
min at 4 °C, boiled several times in 10 mM sodium citrate (pH 6.4) for 5 min, and
permeabilized for 15 min with 0.5% Triton-X-100. Sections were blocked with 10% FBS
in PBS followed by incubation with anti-TIP60 antibody (Frank et al., 2003) and a
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fluorescent secondary antibody (Thermo Fisher Scientific). Nuclei were stained with
DAPI and slides were mounted with Vectashield mounting medium (Vector
Laboratories).
2.4 Molecular Biological Methods
2.4.1 Plasmids
Cry2, Bmal1, Tip60 ORFs were amplified by PCR and cloned into pcDNA3.1 vector
containing either C-terminal myc- or V5-tag. Cry1 ORF was cloned in a pCMV-flag
vector. Single site mutations were introduced by using the QuikChange II Site-directed
Mutagenesis Kit (Agilent Technologies). Tip60V5 and Tip60C369A;E403Q;V5 were cloned
into pLenti PGK Hygro DEST vector. Lentiviral Bmal1-dLuc reporters were from S.A.
Kay (USC Los Angeles). pBABE-puro SV40 LT (#13970), pCL-Eco (#12371), pMD2.G
(#12259), psPAX2 (# 12260), and pLenti PGK Hygro DEST (#19066) plasmids were
from Addgene. Plasmids used in this study are listed in Table 3.
Table 3: Recombinant DNA
Resource Source
pcDNA3.1/TIP60-V5 This study
pcDNA3.1/TIP60C369A;E403Q-V5 This study
pcDNA3.1/BMAL1-myc This study
pcDNA3.1/BMAL1K538R-myc This study
pcDNA3.1/CRY2-V5 This study
pCMV/CRY1-flag This study
BMAL1-flag Gift by M.J. Rossner (LMU Munich)
myc-CLOCK Gift by P. Sassone-Corsi (UC Irvine)
myc-CLOCKmutA Gift by P. Sassone-Corsi (UC Irvine)
pLenti PGK Hygro DEST (w530-1) Addgene Plasmid #19066
pLenti PGK Tip60-V5 This study
pLenti PGK TIP60C369A;E403Q-V5 This study
pLV6-Bmal1-dLuc (Liu et al., 2008)
pBABE-puro SV40 LT Addgene Plasmid #13970
pCL-Eco Addgene Plasmid #12371
pMD2.G Addgene Plasmid #12259
psPAX2 Addgene Plasmid #12260
pSpCas9(BB)-2A-Puro (PX459) Addgene Plasmid #48139
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pL451 NCI at Frederick
pL452 NCI at Frederick
TIP60 BAC (bMQ-331N14) Wellcome Trust Sanger Institute
TIP60 targeting construct This study
TIP60 BAC (RP23-156A18) Children's Hospital Oakland Research Institute
LSL-Tip60-FLAG BAC This study
2.4.2 Cell Culture
Tip60fl/- Mouse embryonic fibroblasts (MEFs) were isolated following standard
procedures (Durkin et al., 2013) from day 13.5 embryos. MEFs, fibroblasts (NIH-3T3
Bmal1-LUC (Nagoshi et al., 2004) and CryWT/CryDKO (Gauger and Sancar, 2005), and
HEK293T cells were cultured and passaged in standard medium (DMEM, high glucose,
GlutaMAX supplement, pyruvate; 10% fetal bovine serum; 100 U/ml penicillin and 100
µg/ml streptomycin [all Thermo Fisher Scientific]) at 37 °C in a humidified incubator
with 5% CO2. MEFs and fibroblasts were synchronized by treatment with 100 nM
dexamethasone (Sigma-Aldrich), a synthetic glucocorticoid that induces expression of
Per1 gene (Reddy et al., 2009, 2012). 500 nM JQ1 (Cayman Chemical), 300 nM
flavopiridol (Santa Cruz Biotechnology) or vehicle (final 0.05% DMSO) were added to
standard medium after synchronization.
2.4.3 Transfection and Viral Transduction
HEK293T cells were transiently transfected using 1 mg/ml polyethylenimine solution
(Sigma-Aldrich). After two days, cells were used for Western blotting and
immunoprecipitations (IPs). Tip60fl/- MEFs were immortalized with SV40 LT retrovirus.
Immortalized MEFs were grown to confluence and transduced with AdGFP or AdCre
adenoviruses (Vector Development Laboratory, Baylor College of Medicine, Houston,
TX, USA) in standard medium containing 3% fetal bovine serum (low-serum) and 8
µg/ml polybrene (Sigma-Aldrich). After two days, medium was changed to low-serum
medium and cells were cultured for another 4 - 6 days. For lentiviral transduction, viruses
were produced according to standard protocol (Ramezani and Hawley, 2002) and
concentrated using Lenti-X Concentrator (Clontech). MEFs were infected in low-serum
medium supplemented with 8 µg/ml polybrene (Sigma-Aldrich) and transduced cells
were selected with 10 µg/ml hygromycin B (Alfa Aesar) or 10 µg/ml blasticidin (Alfa
Aesar) and further propagated.
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2.4.4 Knock-Down Experiment
Tip60-/-; Tip60V5 MEFs were reverse transfected with siRNA. AllStars Negative Control
siRNA (Qiagen) was used as scrambled control. For depletion of Cry1 or Cry2, a mix of
FlexiTube GeneSolution siRNAs (Qiagen) was used. Briefly, 1 x 106 cells were seeded
in 10-cm dishes in standard medium without antibiotics. siRNA mix was added to the
OptiMEM, Lipofectamine 2000 solution (Thermo Fisher Scientific) to a final
concentration of 20 nM, incubated for 20 min at room temperature, and added to the cells.
On the next day medium was changed to standard medium and cells were allowed to grow
for an additional 3 days before harvesting for ChIP.
2.4.5 Preparation of Cell Extracts and Nuclear Extracts
Transiently transfected HEK293T cells were lysed in 50 mM Tris-HCl, pH 8.0; 150 mM
NaCl; 5 mM EDTA; 15 mM MgCl2; 1% NP40; 1 mM DTT; 10 mM NaF; 10 mM NAM;
Complete EDTA-free Protease Inhibitor Cocktail (Roche) for 30 min on ice and lysate
was cleared by centrifugation (20,000 x g, 4 °C, 10 min). Samples were boiled in SDS
sample buffer or used for IP. Anti-Myc or anti-V5 conjugated agarose beads (Sigma-
Aldrich) were used to precipitate myc- and V5-tagged proteins, respectively. The
precipitates were washed three times with lysis buffer and bound proteins eluted by
denaturation in SDS sample buffer.
Cells were fractionated as described (Méndez and Stillman, 2000). Briefly, cells were
suspended in Buffer A (10 mM HEPES, pH 7.9; 10 mM KCl; 1.5 mM MgCl2; 0.34 M
sucrose; 10 % glycerol; 1 mM DTT; Complete EDTA-free protease inhibitor cocktail
[Roche]). Triton X-100 was added to a final concentration of 0.1 % and cells were
incubated for 8 min on ice. Nuclei were collected by centrifugation (1,300 x g, 4 °C, 5
min) and supernatant (fraction S1) was cleared by centrifugation (20,000 x g, 4 °C, 5 min)
and designated as S2. Nuclei were washed with Buffer A and lysed in Buffer B (3 mM
EDTA; 0.2 mM EGTA; 1 mM DTT; Complete EDTA-free Protease Inhibitor Cocktail
[Roche]) for 30 min on ice. Chromatin was pelleted by centrifugation (1,700 x g, 4 °C, 5
min) and supernatant collected and designated as S3. Chromatin (P3) was washed once
with Buffer B and denatured in SDS sample buffer. Samples were analyzed by Western
blotting.
Nuclear extracts from HEK293T, fibroblasts and MEFs were prepared as described
(Dimauro et al., 2012). Cells were washed twice with ice cold PBS and lysed with buffer
STM (50 mM Tris-HCl, pH 7.4; 5 mM MgCl2; 250 mM sucrose; 10 mM NAM; Complete
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EDTA-free Protease Inhibitor Cocktail [Roche]) for 30 min. Nuclei were collected by
centrifugation (800 x g, 4 °C, 15 min) and washed once with STM buffer. Nuclei were
collected by centrifugation (500 x g, 4 °C, 15 min) and resuspended in buffer NET (20
mM HEPES pH 7.9; 1.5 mM MgCl2; 500 mM NaCl; 0.2 mM EDTA; 20% glycerol; 1%
Triton-X-100; 10 mM NAM; Complete EDTA-free Protease Inhibitor Cocktail [Roche]).
Samples were vortexed at maximum speed for 15 s and incubated on ice for 30 min.
Nuclei were lysed with 15 passages through an 18-gauge needle, sonicated using
Bioruptor (30 sec ON / 30 sec OFF) and cleared by centrifugation (9,000 g, 4 °C, 30 min).
For Western blotting samples were denatured in SDS sample buffer. For IPs samples were
diluted 3-fold in dilution buffer (20 mM HEPES pH 7.9; 1.5 mM MgCl2; 0.2 mM EDTA;
20% glycerol; 10 mM NAM; Complete EDTA-free Protease Inhibitor Cocktail [Roche])
and incubated for 2 hours at 4 °C on a rotating wheel. Antibody was added and samples
were put back on the rotating wheel. The next day, antibody-protein complexes were
collected by Dynabead Protein G Beads (Thermo Fisher Scientific) and washed three
times with wash buffer (20 mM HEPES pH 7.9; 1.5 mM MgCl2; 166 mM NaCl; 0.2 mM
EDTA; 20% glycerol; 0,33% Triton-X-100; 10 mM NAM; Complete EDTA-free
Protease Inhibitor Cocktail [Roche]). Proteins were eluted by boiling in SDS sample
buffer and analyzed by Western blotting.
Nuclear extracts from liver samples were prepared using NE-PER Nuclear and
Cytoplasmic Extraction Reagents (Thermo Fisher Scientific) according to manufacturer’s
instructions. Briefly, samples were homogenized using a Dounce homogenizer in ice cold
CRE I buffer and incubated on ice for 15 min. Nuclei were collected by centrifugation
(16,000 x g, 4 °C, 5 min) and resuspended in NER buffer. Samples were vortexed at
maximum speed for 15 s every 10 min, for a total of 60 min and cleared by centrifugation
(16,000 g, 4 °C, 10 min). For Western blotting, samples were denatured in SDS sample
buffer. For IPs antibody was added and samples were put on the rotating wheel. The next
day, antibody-protein complexes were collected by Dynabead Protein G Beads (Thermo
Fisher Scientific) and washed three times with wash buffer (10 mM Tris-HCl, pH 8.0;
150 mM NaCl; 5 mM EDTA; 15 mM MgCl2; 1% NP40; 1 mM DTT; 10 mM NaF; 10
mM NAM; Complete EDTA-free Protease Inhibitor Cocktail [Roche]). Proteins were
eluted by boiling in SDS sample buffer and analyzed by Western blotting.
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2.4.6 Western Blotting
Samples were resolved on 4–15% gradient TGX precast gels (Bio Rad) and proteins were
transferred onto PVDF membranes using the Trans-Blot Turbo Transfer System (Bio
Rad). Membranes were blocked with 5% non-fat milk or 3% BSA and incubated with
primary antibodies overnight at 4 °C. Membranes were incubated for 2 hours at room
temperature with appropriate HRP-conjugated secondary antibodies and developed with
SuperSignal Chemiluminescent Substrate (Thermo Fisher Scientific). Signal intensities
were determined on an ImageQuant LAS4010 imager (GE Healthcare) and quantified
using ImageQuant software (GE Healthcare). Antibodies against CDK9 (sc-484) and
Actin (sc-1616-HRP) were purchased from Santa Cruz Biotechnology, BRD4 (A301-
985A) from Bethyl, BMAL1 (NB100-2288) from Novus, acetylated BMAL1 (AB15396)
from Millipore, TBP (ab197874-HRP) from Abcam, FLAG M2 (A8592-HRP) from
Sigma-Aldrich, V5 (R961-25-HRP) and myc (R951-25-HRP) from Thermo Fisher
Scientific, GST (RPN1236-HRP) from GE Healthcare, acetylaed Lysine (9441S), goat
anti-rabbit HRP (7074) and mouse anti-rabbit (conformation specific) HRP (5127S) from
Cell Signaling Technology, and goat anti-rat HRP (ab97180) and goat anti-guinea pig
HRP (A18775) from Abcam. Antibodies against TIP60 were provided by Dr. J.W. Lough
(Fisher et al., 2016) and Dr. B. Amati (Frank et al., 2003), against CRY1 by Dr. J.A.
Ripperger (Stratmann et al., 2010), and against CRY2 by Dr. J.S. Takahashi (Koike et al.,
2012).
2.4.7 Chromatin Immunoprecipitation (ChIP)
For BMAL1 (NB100-2288; Novus), acetylated BMAL1 (AB15396; Millipore), BRD4
(A301-985A; Bethyl), CDK9 (sc-484 and sc-13130; Santa Cruz Biotechnology), Pol II
(MABI0601; BIOZOL), Ser2 phosphorylated Pol II (04-1571; Millipore) and TFIIEα
(ab28177; Abcam) ChIP analysis were performed as described (Lin et al., 2012; Rahl et
al., 2010) with minor modifications. Fibroblasts were crosslinked with 1% formaldehyde
for 10 min at room temperature. The reaction was stopped by adding 125 mM glycine
and incubating for 5 min. Cells were washed twice with PBS, scraped and frozen in liquid
nitrogen. Dynabead Protein G Beads (Thermo Fisher Scientific) were blocked with 0.5%
BSA (w/v) in PBS and bound to the indicated antibodies. Crosslinked cells were lysed in
lysis buffer 1 (50 mM HEPES pH 7.3; 140 mM NaCl; 1 mM EDTA; 10% glycerol; 0.5%
NP-40; 0.25% Titon-X-100; 10 mM NAM; Complete EDTA-free Protease Inhibitor
Cocktail [Roche]; PhosSTOP Phosphatase Inhibitor Cocktail [Roche]) and washed with
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lysis buffer 2 (10 mM Tris-HCl pH 8.0; 200 mM NaCl; 1 mM EDTA; 0.5 mM EGTA;
10 mM NAM; Complete EDTA-free Protease Inhibitor Cocktail [Roche]; PhosSTOP
Phosphatase Inhibitor Cocktail [Roche]). Pellets were resuspended and sonicated in lysis
buffer 3 (50 mM Tris-HCl pH 7.5; 140 mM NaCl; 1 mM EDTA; 1 mM EGTA; 1% Triton-
X-100; 0.1% SDS; 0.1% Na-deoxycholate; 10 mM NAM; Complete EDTA-free Protease
Inhibitor Cocktail [Roche]; PhosSTOP Phosphatase Inhibitor Cocktail [Roche])
(Bioruptor; 30 sec ON / 30 sec OFF) to obtain chromatin fragments of 150-600 bp length.
Sonicated lysates were cleared and incubated overnight at 4 °C with beads bound with
antibody for indicated factors. Beads were washed twice (CDK9 and Pol II Ser2P) or
three times (BMAL1, AcBMAL1, Pol II, and BRD4) with lysis buffer 3, once with lysis
buffer 3 with 500 mM NaCl, one time with LiCl wash buffer (10 mM Tris-HCl pH 8.0;
250 mM LiCl; 1 mM EDTA; 0.5% NP-40; 0.5% (50 mM Tris-HCl pH 7.5; 140 mM
NaCl; 1 mM EDTA; 1 mM EGTA; 1% Triton-X-100; 0.1% SDS; 0.1% Na-deoxycholate)
and one time with TE plus 50 mM NaCl. DNA was eluted in elution buffer (50 mM Tris-
HCl pH 8.0; 10 mM EDTA; 1% SDS). The eluted complexes were de-crosslinked
overnight and RNA and protein were digested using RNase A (Qiagen) and Proteinase K
(Thermo Fisher Scientific). Immunoprecipitated DNA fragments were purified by phenol
chloroform extraction and ethanol precipitation and used for qPCR analysis.
For TIP60V5 (R960-25; Thermo Fisher Scientific), CRY1 (Ye et al., 2011) and CRY2
(Koike et al., 2012) in cells and BMAL1 (NB100-2288; Novus) and acetylated BMAL1
(AB15396; Millipore) in liver ChIP assays were performed as described (Adli and
Bernstein, 2011; Nelson et al., 2006) with minor modifications. Cells and liver were
cross-linked with 1% formaldehyde for 15 min at room temperature. For dual cross-
linking (Zeng et al., 2006) Tip60-/-; Tip60V5 MEFs were fixed with 1.5 mM ethylene
glycol bis(succinimidylsuccinate) (EGS) (Thermo Fisher Scientific) for 30 min followed
by 1% formaldehyde for another 15 min. After quenching the reaction by adding glycine
to a final concentration of 125 mM, cells were lysed in SDS lysis buffer (50 mM Tris-
HCl, pH 8.1; 100 mM NaCl; 5 mM EDTA; 1% SDS; Complete EDTA-free Protease
Inhibitor Cocktail [Roche]) on ice for 10 min, with brief vortexing. Liver was
homogenized using a Dounce homogenizer in SDS lysis buffer and incubated on ice for
15 min. Samples were diluted 10-fold in ChIP dilution buffer (16.7 mM Tris-HCl, pH
8.1; 167 mM NaCl, 1.2 mM EDTA; 1.1% Triton X-100; 0.01% SDS; Complete EDTA-
free Protease Inhibitor Cocktail [Roche]) and sonicated (Bioruptor; 30 sec ON / 30 sec
OFF) to obtain chromatin fragments of 150 - 600 bp length. Appropriate antibodies were
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added to the chromatin solution and incubated overnight at 4 °C on a rotating wheel. For
anti-CRY2 antibody Dynabead Protein A Beads (Thermo Fisher Scientific) were used,
for anti-V5, BMAL1, and acetylated BMAL1 antibodies Dynabead Protein G Beads
(Thermo Fisher Scientific) were used, and for anti-CRY1 antibody Protein L Magnetic
Beads (Pierce) were used. Immunoprecipitated chromatin complexes were washed twice
with ice cold low-salt wash buffer (20 mM Tris-HCl, pH 8.1; 150 mM NaCl; 2 mM
EDTA; 1% Triton X-100; 0.1% SDS), twice with ice cold lithium chloride wash buffer
(10 mM Tris-HCl, pH 8.1; 250 mM LiCl; 1 mM EDTA; 1% NP40; 1% deoxycholate),
and twice with ice cold TE buffer (10 mM Tris-HCl, pH 8; 1 mM EDTA). 100 µl 10%
Chelex 100 Slurry (Bio Rad) was added directly to the washed beads, briefly vortexed,
and boiled for 10 min. Input DNA samples were ethanol precipitated and washed with
70% ethanol. DNA pellets were dissolved in 100 µl 10% Chelex 100 suspension and
boiled for 10 min. Samples were proteinase K (Thermo Fisher Scientific) treated and
boiled for 10 min. Supernatant was transferred to a new tube and used for qPCR analysis.
For validation of the antibodies, the Dbp gene was used and deficient cells or antibody
isotype controls were applied to evaluate the ChIP-grade quality of the antisera (Figure
10). Primer pair that targets an unbound region was used as internal control (Duong et al.,
2011) and fold enrichment was calculated using the 2^(-ΔΔCT) method. Experiments
were performed with biological independent triplicates and data normalized to the mean
value obtained from the locus with the strongest enrichment. Primer sequences for ChIP-
qPCR are listed in Table 4.
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Figure 10: Validation of Antibodies used for ChIP Studies.
Deficient cells when possible or antibody isotype controls were used to validate the ChIP-
grade quality of the antisera. The test gene used was Dbp. Data are shown as mean ± SEM
(n = 3; **p < 0.01, and ***p < 0.001 Student’s t-test).
Table 5: Primer Sequences used for ChIP-qPCR analysis
Target Forward (5’ – 3’) Reverse (5’ – 3’)
Dbp -0.4 ACACCCGCATCCGATAG CCACTTCGGGCCAATGAG
Dbp -0.2 ACACAAGTTCAGCCCCTCAC GGCAAGAACCAATCACGTCT
Dbp TSS AAGCTCCTTTCTTTGCGAGA TCAAGCAGCTGTCTCTTTGC
Dbp +0.2 TCTGCAGAGCAGACTGGTTGA GCGTGCAAACCTCCAGGAT
Dbp +0.8 ATGCTCACACGGTGCAGACA CTGCTCAGGCACATTCCTCAT
Dbp +2.4 TGGGACGCCTGGGTACAC GGGAATGTGCAGCACTGGTT
Dbp +4.4 AAGAACAATGAAGCAGCCAAGAG GGCAGCCCGCACAGATAT
Dbp +5.2 GGCACCGGAGTAGGCAAGA GCCTGGAATGTATGAGCTAGCA
Per1 -1.5 CACCATGCCCAGCTTAGAA CACCTTTGGAAGAGCAGTCA
Per1 -0.5 GGCACCAGAAACCTCTTGTA CCTTGACGACACTTACCCAATA
Per1 TSS GTGTGAGGGATCATGCAAATG CTAGAGTTGAACTTGTGGTCTCT
Per1 +0.5 GGATTCTGAAAGGGAGGATAAGG CAGAGCAGTCCTTTGGTAACT
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Per1 +4.9 CCGAGGCCTCAGAGTCCCA GGCCATCTCTTACACCCCTT
Per1 +14.3 TGGACAGACCACTTCAGCAG GAAGTTCTCAGCCCCATTTG
Rev-Erbα -2.1 AGCTAGTGAGAAGAGGGAACTA GCTTCATACCTCACACAGACTAC
Rev-Erbα -0.5 ACAAGCTGGGAGGAGAGAT GGGTTAGGGTGAAGAAGAGAAAG
Rev-Erbα TSS AGGCACACTCCACCTACATTGTCA TGGAGCAGGTACCATGTGATTCCA
Rev-Erbα +0.1 CGCTCGGAACTGTGAGTAG GGCATTTGTTCTGCAGCTAAT
Rev-Erbα +2.0 TCATGCCCTCTTTCAGGATT TTACCCGGCTATGGTTTCAC
Rev-Erbα +6.8 CTCCTTCTCCTTTCCCGTTG CCTGAGCTCCTCCTCTGACA
Control TGCTAGATGCTGCGGAAGAACTGA TCTCTATGCTCCCAGCCAAGGTAT
2.4.8 RNA Analysis by Quantitative Real-Time PCR (qPCR)
Total RNA was extracted using RNeasy Plus Mini Kit (Qiagen). Cells were directly lysed
in the vessel and liver samples were homogenized using the Bead Ruptor (Biolabs).
cDNA was synthesized using Maxima H Minus First Strand cDNA Synthesis Kit
(Thermo Fisher Scientific). Real-time PCR reactions were performed on a CFX96 Real-
Time PCR Detection System (Bio-Rad) with IQ SYBR Green Supermix (Bio-Rad). Eef1a
or Gapdh expression was used for normalization. Primers used for qPCR analysis are
listed in Table 6.
Table 6: Primer Sequences used for qPCR analysis
Target Forward (5’ – 3’) Reverse (5’ – 3’)
Eef1a TGCCCCAGGACACAGAGACTTCA AATTCACCAACACCAGCAGCAA
Gapdh CATGGCCTTCCGTGTTCCTA CCTGCTTCACCACCTTCTTGA
18S AGTCCCTGCCCTTTGTACACA GATCCGAGGGCCTCACTAAAC
ActB TTGTCCCCCCAACTTGATGT CCTGGCTGCCTCAACACCT
36B4 AGATGCAGCAGATCCGCAT GTTCTTGCCCATCAGCACC
Dbp AATGACCTTTGAACCTGATCCCGCT GCTCCAGTACTTCTCATCCTTCTGT
Per1 AGTTCCTGACCAAGCCTCGTTAG CCTGCCCTCTGCTTGTCATC
Per2 GCCAAGTTTGTGGAGTTCCTG CTTGCACCTTGACCAGGTAGG
Rev-Erbα AGCTCAACTCCCTGGCACTTAC CTTCCTCGGAATGCATGTTGTTC
Bmal1 CCTAATTCTCAGGGCAGCAGAT TCCAGTCTTGGCATCAATGAGT
Tip60 GCCTGGACGGAAGCGGAAAT CAATGTCGTGGCTCCGGT
c-Fos TTCCTGGCAATAGCGTGTTC TTCAGACCACCTCGACAATG
c-Jun GAAGTGACGGACCGTTCTATGAC GGAGGAACGAGGCGTTGAG
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2.4.9 Radioactive In Situ Hybridization
In situ hybridization with 35S-labeled antisense RNA probes was carried out on frozen
sections through the SCN by Dr. Henrik Oster. Relative quantification of expression
strength was performed by densitometric analysis of autoradiograph films. Templates for
Dbp, Per1, and Bmal1 were as described (Oster et al., 2003, 2006).
2.4.10 Genotyping
Ear biopsies or cells were lysed in 10 mM Tris-HCl pH 8.3; 50 mM KCl; 2.5 mM MgCl2;
0.1 mg/ml gelatin; 0.45 % NP40; 0.45 % Tween-20; 0.015 µg/µl Proteinase K (Thermo
Fisher Scientific) over night or for 2 h at 55 °C followed by Proteinase K inactivation at
85 °C for 1 h.
Genotyping PCR was performed using GoTaq Flexi DNA Polymerase (Promega)
according to manufacturer’s instructions and resolved by agarose gel electrophoresis.
Both steps were mainly done by the technical staff. Primer sequences and PCR product
sizes are listed in Table 7.
Table 7: Primer Sequences used for Genotyping
PCR Primer Sequence (5’ – 3’) PCR product
Tip60 Tip60 P1 TCAGAAGATGCACCTTCTGCTGG WT: 331 bp
Tip60 P2 GGAAGGTTCAAAATTCCAGTAGGC Floxed: 429 bp
Tip60 P3 TGCTTCCGCTTCCTGAATGCTG Deleted: 487 bp
Syt10 Syt10 fw AGACCTGGCAGCAGCGTCCGTTGG WT: 420 bp
Syt10 rev AAGATAAGCTCCAGCCAGGAAGTC KI: 550 bp
Syt10 KI
rev GGCGAGGCAGG CCAGATCTCCTGTG
Bmal1 Bmal1 P1 TGGAGCACAGCTGCACTTAT 438 bp
Bmal1 P2 AAGTCCCAGCTGCACACAAG
Clock Clock P1 AGCTGGGGTCTATGCTTCCT WT:280 bp
Clock P2 CGCTGAGAGCCAAGACAAT Floxed: 380 bp
Clock P3 CAGCTTCATTTGAAATCTGCAT Deleted: 450 bp
BAC-FLAG FLAG P1 AGTGAGATCAGTGAAATCACTAG WT: 573 bp
FLAG P2 CTGTGTACATTAAGATGGGTGG FLAG: 726 bp
BAC-STOP STOP P1 CGTTCCTCCAATCGCTGTGCG WT: 403
STOP P2 CGGCGCAACCAGGACAACGAA Floxed: 649 bp
STOP P3 CATCAATGTATCTTATCATGTCTG Deleted: 479 bp
Tip60-BAC BAC P1 GTTGACAAGTCCGCTCCTTC Tip60 WT: 652 bp
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BAC P2 GAACTGAGCGAACAAGTGCA Tip60 floxed: 750 bp
BAC P3 CATCTTCCCTCCCTCCACTG Tip60 deleted: 434 bp
BAC P4 CCTGCATGTCTGAACCCAAC BAC floxed: 1008 bp
BAC deleted: 728 bp
AlbCre Cre P1 CGATGCAACGAGTGATGAGGTTCG pos: 300 bp
Cre P2 AGCATTGCTGTCACTTGGTCGTGG neg: none
2.4.11 TUNEL Assay
TUNEL assay on sections through the SCN using an In Situ Cell Death Detection Kit
(Roche) was performed according to manufacturer’s instructions. As a positive control,
sections were treated with DNaseI (New England Biolabs) for 10 min to induce DNA
fragments and single strand breaks. Nuclei were stained with DAPI and slides were
mounted with Vectashield mounting medium (Vector Laboratories).
2.4.12 Bioluminescence Recording
After synchronization of cells with dexamethasone medium was changed to recording
medium (DMEM with high glucose, without glutamine and phenol red; 2 mM
GlutaMAX; 10 mM HEPES; 5% FBS; 100 U/ml penicillin and 100 µg/ml streptomycin
[all Thermo Fisher Scientific] and 0.1 mM D-luciferin [Synchem]). Petri dishes were
sealed with transparent plastic film and bioluminescence was recorded in a LumiCycle
luminometer (Actimetrics).
For JQ1 and flavopiridol dose dependence experiments, NIH-3T3 Bmal1-LUC fibroblasts
were plated on 35-mm dishes and cultured for 2 days to reach confluency. Cells were
synchronized and medium was replaced with the recording medium containing various
concentrations of JQ1 (Cayman Chemical) and flavopiridol (Santa Cruz Biotechnology)
or vehicle (final 0.08% DMSO). For calculation of period, luminescence intensity, and
damping rate parameters the curve fitting program LumiCycle (Actimetrics) was used
and data obtained from the first day were excluded from analysis because of transient
luminescence changes upon the medium change.
2.4.13 In Vitro Acetylation Assay
Recombinant TIP60 (SignalChem) and BMAL1 (Abnova) proteins were mixed in
acetyltransferase assay buffer (50 mM Tris-HCl, pH 8.0; 0.1 mM EDTA; 0.4 mM DTT;
25 ng/ µl BSA; 5% glycerol) in the presence or absence of 10µM acetyl-CoA (Sigma-
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Aldrich) and incubated for 1 h at 30 °C. The reaction was stopped by denaturation in SDS
sample buffer and proteins were analyzed by Western blotting.
2.4.14 Flow Cytometry
Cells were stained using the SYTOX AADvanced Dead Cell Stain Kit (Thermo Fisher
Scientific) according to the manufacturer’s instructions and samples were analyzed using
the Accuri C6 Flow Cytometer (BD). To provide a positive control cells were boiled for
3 min.
2.5 Statistical Analysis
Statistical analyses were performed using GraphPad Prism 5 software (GraphPad
Software) and all data are presented as mean +/- SEM. For comparison between two
groups a two-tailed student’s t-test was applied. Significant differences between multiple
groups were evaluated using two-way ANOVA with Bonferroni post-tests and results are
listed in Table 8.
Table 9: Two-way ANOVA Statistical Analysis
two-way ANOVA main effects Bonferroni post-test
Gene Time (p) Genotype (p) Interaction (p) p-values below 0.05 are shown
Figure 16 Dbp < 0.0001 < 0.0001 < 0.0001 Clone 1/2/3: 24/28/32/36/40/44: < 0.001
Per1 < 0.0001 < 0.0001 < 0.0001 Clone 1: 24/28/32/36/44: < 0.001; 40 < 0.01
Clone 2: 24/28/44: < 0.001; 32 < 0.05
Clone 3: 24/28/40/44: < 0.001; 32/36: <
0.05
Rev-Erbα < 0.0001 < 0.0001 < 0.0001 Clone 1: 24/28/40/44: < 0.001; 32 < 0.01
Clone 2: 24/28/32/36/40/44: < 0.001
Clone 3: 24/28/32/36: < 0.001
Figure 20 Per1 < 0.0001 < 0.0001 < 0.0001 CT 0/24: < 0.01; CT 6: < 0.0001
Bmal1 0.0002 0.0005 0.2175 CT 18: < 0.01
Dbp < 0.0001 0.0002 0.0006 CT 6: < 0.0001; CT12: < 0.05
Figure 21D Dbp < 0.0001 < 0.0001 < 0.0001 24/28/32/36/40/44: < 0.0001
Figure 21F Dbp < 0.0001 < 0.0001 < 0.0001 24/36/40: < 0.001; 28/32/44: < 0.0001
Nr1d1 < 0.0001 0.0012 < 0.0001 24: < 0.001; 28: < 0.0001
Per1 0.0002 < 0.0001 0.0002 24/28/32/36/40/44: < 0.0001
Per2 < 0.0001 < 0.0001 < 0.0001 24/28/32/36/44: < 0.0001; 40: < 0.01
Bmal1 < 0.0001 < 0.0001 0.0007 36/40: <  0.0001; 44: <0.01
Gapdh 0.2918 0.0079 0.5568 -
Gene Time (p) Treatment (p) Interaction (p) p-values below 0.05 are shown
Figure 12 Dbp < 0.0001 < 0.0001 < 0.0001 24/28/32/36/40/44: < 0.001
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3.1 Inhibition of CDK9 and BRD4 Abolishes Circadian Oscillations
Synchronized fibroblasts stably expressing the clock-driven luciferase reporter Bmal1-
LUC (Nagoshi et al., 2004) show sustained reporter expression with a period of ~26 h. In
the presence of flavopiridol (FP), a potent inhibitor of CDK9 subunit of P-TEFb (Chao
and Price, 2001; Chao et al., 2000; Rahl et al., 2010), the amplitude of luciferase activity
rhythms was suppressed in a dose dependent manner concomitant with an increased
period length until, at high doses, the rhythm was fully lost (Figure 11A and B). Treatment
of fibroblasts with FP also strongly reduced endogenous mRNA expression levels of Dbp,
Per1, and Rev-Erbα (Figure 11C) that are direct CLOCK-BMAL1 targets (Stratmann et
al., 2012). These findings suggest that circadian clock gene regulation not only occurs at
Figure 11: RNA Pol II Pause Release Is a Regulatory Step of Clock Gene Expression.
(A) Bioluminescence recordings of dexamethasone (Dex) synchronized Bmal1-LUC
fibroblasts treated with increasing concentrations of flavoperidol (FP) (n = 4). (B) Change
of period, luminescence intensity, and damping rate relative to DMSO control (n = 4).
LR: loss of rhythm. (C) mRNA expression analysis of fibroblasts treated with either
DMSO or flavopiridol (300 nM) carried out 24 hours after Dex synchronization. Data are
shown as mean ± SEM (n = 3; ***p < 0.001, Student’s t-test).
the initiation of transcription (Koike et al., 2012; Le Martelot et al., 2012) but also at the
level of RNA Pol II pause release and productive elongation. Triazolothienodiazepine
(JQ1) is a potent and selective inhibitor of BRD4 (Shi and Vakoc, 2014). JQ1 treatment
of Bmal1-LUC reporter fibroblasts dampened luciferase activity rhythms in a dose-
dependent manner and evoked a lengthening of the period (Figure 12A and B). This effect
was reversible upon washout of JQ1 (Figure 12C). Thus, perturbation of circadian
rhythms is due to dysfunction within the circadian system and not to cell toxicity or
apoptosis. JQ1 also resulted in a strong dampening of the rhythm of endogenous Dbp
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expression in these cells (Figure 12D). In the presence of JQ1, enrichment of BRD4 and
CDK9 at the TSS of Dbp was markedly reduced (Figure 12E). Ser2 phosphorylation of
Pol II, at the 3’-end of Dbp, was strongly diminished (Figure 12F) suggesting that RNA
Figure 12: BRD4 Controls Clock Gene Expression.
(A) Bioluminescence recordings of dexamethasone (Dex) synchronized Bmal1-LUC
fibroblasts treated with increasing concentrations of JQ1 (n = 4). (B) Change of period,
luminescence intensity, and damping rate relative to DMSO control (n = 4). (C)
Bioluminescence recording of Dex-synchronized Bmal1-LUC fibroblasts before and after
wash out of 500 nM JQ1 (n = 4). (D) Dbp mRNA dampening in Dex-synchronized
fibroblasts by 500 nM JQ1 (n = 3; two-way ANOVA, see Table 10. (E and F) ChIP
analysis of BRD4 and CDK9 (E) and Ser2-phosphorylated RNA Pol II (normalized to
total RNA Pol II) (F) for the Dbp gene carried out 24 hours after Dex synchronization of
the cells (n = 3). Schematic diagrams show the genomic structure of the Dbp locus.
Horizontal lines represent PCR-amplified genomic regions. All data are shown as mean
± SEM. Note that Dbp has several additional intronic RNA Pol II pausing sites (Sobel et
al., 2017). For validation of ChIP-grade quality of antibodies see Figure 10.
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Pol II pause release was suppressed (Harlen and Churchman, 2017). Reduced Dbp
expression could be due to lower levels of BMAL1 and not abrogated BRD4-P-TEFb
recruitment. To show that this is not the case, constitutively ectopic CMV promoter-driven
Bmal1-myc was expressed in BMAL1-deficient cells. BRD4 inhibition by JQ1 strongly
reduced endogenous expression levels of Dbp mRNA but had no effect on mRNA or
protein levels of Bmal1-myc (Figure 13A). Furthermore, BRD4 inhibition neither affected
endogenous mRNA nor protein levels of Bmal1 (Figure 13B) in Bmal1-LUC fibroblasts
at 24 hours after Dex synchronization. Finally, the binding of BMAL1 and of acetylated
BMAL1 (AcBMAL1) protein to the Dbp promoter was not affected by BRD4 inhibition
in these cells (Figure 13C). Together, our inhibitor studies suggest that BRD4-P-TEFb is
recruited to the E-box-containing clock-controlled gene Dbp, which subsequently allows
RNA Pol II pause release and transcription elongation. Thus, for this circadian clock-
controlled gene, RNA Pol II pause release may serve as an important regulatory step of
its transcription.
Figure 13: BRD4 Inhibition Does Not Directly Affect Bmal1 Expression.
(A) Immunoblot and mRNA expression analysis of Dex-synchronized (24 hours after)
Bmal1-/- MEFs transfected with empty vector or Bmal1-myc treated with either DMSO or
JQ1 (50 0 nM) (n = 3). (B) BMAL1 protein abundance and Bmal1 mRNA expression in
DMSO or JQ1 (500 nM) treated cells isolated 24 hours after Dex synchronization (n = 3).
(C) ChIP analysis of BMAL1 and acetylated BMAL1 for the Dbp gene carried out 24 h
after Dex synchronization of MEFs (n=3). (D) Interaction of BMAL1 with BRD4 in
fibroblasts treated with either DMSO or JQ1 (500 nM). Immunoblots show results with
increasing equivalents of IPs (two-fold dilutions) from nuclear extracts isolated from cells
24 hours after Dex synchronization. All data are shown as mean ± SEM (n = 3; ns > 0.05
and ***p < 0.001, Student’s t-test).
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3.2 Acetylation of BMAL1 at Lysine 538 is Required to Initiate
Circadian Productive Transcription Elongation
BRD4 binds to acetylated lysines of transcription factors/histones at the promoter of
paused genes (Shi and Vakoc, 2014). The observed strong effect of JQ1 on the cellular
circadian rhythm raises the possibility that among BRD4 targets there are core clock
components, such as BMAL1, which is acetylated at Lys538 (Hirayama et al., 2007) and
could therefore provide a binding site for BRD4. This particular lysine was mutated to an
arginine (BMAL1K538R) using the CRISPR/Cas9 technique (Figure 8 and Figure 14A and
B). BMAL1K538R protein was as stable as wildtype BMAL1 (Figure 15A), and subcellular
localization and phosphorylation status of both forms were similar (Hirayama et al.,
2007). Enrichment of both BMAL1 variants to the promoters of the Dbp, Per1, and Rev-
Erbα genes was also found to be unchanged (Figure 14C). Next, the interaction of BRD4
and CDK9 with BMAL1 was examined in control fibroblasts and fibroblasts containing
engineered BMAL1K538R. Immunoprecipitation experiments showed that in BMAL1K538R
expressing cells this interaction was markedly reduced (Figure 15A). When wildtype cells
were JQ1-treated, this interaction was substantially dampened (Figure 13D). ChIP
experiments demonstrated that BMAL1K538R mutant cells showed a diminished
recruitment of BRD4 and of the P-TEFb subunit CDK9 to the TSS of Dbp, Per1, and
Rev-Erbα (Figure 15B). In addition, enrichment of Ser2-phosphorylated RNA Pol II was
markedly reduced (Figure 15B). Since both, control fibroblasts and BMAL1K538R mutant
cells stably expressed a clock-driven luciferase reporter, the effect of the K538R mutation
on luminescence rhythms was assessed. In BMAL1K538R cells virtually no rhythmic
luciferase reporter expression was recorded for any of the 3 clones (Figure 16A). In
addition, in these cells there was a pronounced reduction of peak expression of
endogenous Dbp, Per1, and Rev-Erbα mRNAs (Figure 16B-D). It is possible that
BMAL1 acetylation could additionally promote transcription initiation. However, the
occupancy of the general transcription factor TFIIEα (part of the RNA Pol II transcription
initiation complex (Sainsbury et al., 2015)) at the TSS of Dbp, Per1, and Rev-Erbα genes
was not affected in mutant cells (Figure 17). This favors the idea that transcription
elongation, and not initiation, is the process that is primarily regulated by acetylation of
BMAL1. These data support a mechanism in which acetylated BMAL1 recruits BRD4
and P-TEFb to E-box-containing circadian clock genes which then results in a release of
RNA Pol II from its paused state, thereby allowing productive elongation.
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Figure 14: CRISPR/Cas9-mediated Generation and Characterization of
BMAL1K538R Mutant Cells.
(A) Schematic representation of the gene targeting strategy for generating BMAL1K538R
mutant cells using the CRISPR/Cas9 system. The gRNA-targeting sequence is underlined
and the PAM sequence is indicated in red. The oligonucleotide donor (120 bp) is shown
below the targeted site, with the Lys-to-Arg substitution indicated in red. Silent point
mutations were introduced for the two adjacent Gly to prevent cutting of the donor DNA
or re-cutting of the genome after homology-directed recombination (shown in red). (B)
Representative sequencing results from PCR amplicons of the Lys538 region from three
individual clones that were subsequently used for experimental work. Primer sequences
are specified in Table 11. (C) BMAL1 IPs from wildtype or BMAL1K538R fibroblast
nuclear extracts carried out 24 hours after Dex synchronization of fibroblasts were
immunoblotted with anti-AcBMAL1 and anti-BMAL1 antibodies. (D) ChIP analysis of
BMAL1 binding to Dbp, Per1, and Rev-Erbα genes in wildtype and BMAL1K538R
synchronized fibroblasts 24 hours after Dex synchronization. Data are shown as mean ±
SEM (n = 3; ns > 0.05 Student’s t-test).
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Figure 15: Lys538 Acetylation of BMAL1 Is Essential for Transcription Elongation.
(A) Interaction of BMAL1 or BMAL1K538R with BRD4 and CDK9 as shown by
immunoblotting of BMAL1 IPs from nuclear extracts of synchronized fibroblast 24 hours
after Dex treatment (two-fold dilutions). TBP (TATA-binding protein) was used as
loading control. Numerical values represent intensities of chemiluminescence signals of
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individual bands, normalized to wildtype and loading control for input samples. (B) ChIP
analysis of BRD4, CDK9 and Ser2P-RNA Pol II (normalized to total RNA Pol II) binding
to the Dbp, Per1, and Rev-Erbα genes in wildtype and BMAL1K538R synchronized
fibroblasts as shown in (A). Data are shown as mean ± SEM (n = 3).
Figure 16: Lys538 Acetylation of BMAL1 Controls Clock Gene Expression.
(A) Bmal1-LUC bioluminescence tracings of synchronized wildtype fibroblasts and of
three independent BMAL1K538R clones (n=4). (B - D) Dbp (B), Per1 (C), and Rev-Erbα
(D) mRNA expression analysis of wildtype or BMAL1K538R fibroblasts taken from the
experiment shown in (A) (n = 3, two-way ANOVA, see Table 12). All data are shown as
mean ± SEM.
Figure 17: Acetylation of BMAL1 Is Unlikely to Affect Transcription Initiation.
ChIP analysis of TFIIEα binding to Dbp, Per1, and Rev-Erbα genes in wildtype and
BMAL1K538R synchronized fibroblasts. Data are shown as mean ± SEM (n = 3).
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3.3 TIP60 Acetylates BMAL1 at Lysine 538
BMAL1 acetylation was reported to be carried out by CLOCK (Hirayama et al., 2007).
However, in CLOCK-deficient fibroblasts, BMAL1 was acetylated at Lys538 to a similar
extent as observed in wildtype cells (Figure 18A). CLOCKmutA fails to acetylate histones
H3 and H4 (Doi et al., 2006) and shows greatly diminished activity in the acetylation of
BMAL1 (Hirayama et al., 2007). Both wildtype and mutant CLOCK showed a minimal
increase of BMAL1 acetylation compared to a control sample (Figure 18B). Importantly,
BMAL1 acetylation levels in the presence of CLOCK or CLOCKmutA were
indistinguishable. Together, these data suggest the existence of alternative
acetyltransferases that catalyze BMAL1 acetylation. A candidate is TIP60 that co-purifies
with CLOCK-BMAL1 (Doi et al., 2006) and acetylates a broad range of transcription
factors (Ghobashi and Kamel, 2018; Judes et al., 2015). Co-transfection of BMAL1 with
TIP60, but not enzymatically inactive TIP60C369A;E403Q (Yang et al., 2012), strongly
enhanced Lys538 BMAL1 acetylation regardless of the presence of wildtype or mutant
CLOCK (Figure 18B). Lys538 acetylation of BMAL1 by TIP60 occurred in a dose-
dependent manner and acetyltransferase-deficient TIP60C369A;E403Q, unlike CLOCKmutA,
led to baseline acetylation levels of BMAL1 similar to mock transfected cells (Figure
18C). Lys538 appeared to be the predominant lysine acetylated by TIP60 as the signal
obtained with an anti-pan-AcK antibody was strongly diminished in cells co-transfected
with BMAL1K538R and TIP60 (Figure 18C). Recombinant TIP60GST acetylated
recombinant BMAL1GST at Lys538 (Figure 18D). TIP60 is a nuclear, chromatin-
associated protein (Figure 18E and F) and co-precipitated with wildtype and BMAL1K538R
(Figure 18G) suggesting an interaction between the two proteins directly on the chromatin
that is not influenced by acetylation of BMAL1. Both, BMAL1 and TIP60V5 proteins
bound to the E-boxes of the Dbp gene (Figure 18H) further supporting the idea that
interaction between the two proteins is happening on the DNA. BMAL1 was also the only
E-box associated clock protein (Koike et al., 2012) that was acetylated in a TIP60 activity-
dependent manner (Figure 19A). Although, PER2 was as well found to be acetylated
(Asher et al., 2008), this acetylation was not dependent on TIP60 (Figure 19B). Neither
CRY1, CRY2 nor CLOCK were acetylated (Figure 19A, C and D). Collectively, these
data provide strong evidence that BMAL1 is a direct substrate of TIP60.
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Figure 18: TIP60 Acetylates BMAL1.
(A) BMAL1 IP analysis of control and Clock-deficient MEF nuclear extracts over a 24-
hour time course. For both genotypes, equivalent amounts of BMAL1 were included as
shown in the anti-BMAL1 probed Western blot. Lys538 acetylation of BMAL1 was
detected using an anti-AcBMAL1 antibody (left). Wildtype and mutant cells were PCR-
genotyped to confirm their genotype (right) (DeBruyne et al., 2006). (B and C)
BMAL1FLAG, CLOCKmyc, CLOCKmutA;myc, TIP60V5, and TIP60C369A;E403Q;V5 (n=3) (B)
and BMAL1myc, BMAL1K538R,myc, TIP60V5, and TIP60C369A;E403Q;V5 (C) were transiently
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overexpressed in HEK293T cells in the combinations indicated. Lysates were subjected
to IPs and immunoblotted with antibodies indicated. (D) Recombinant BMAL1GST,
TIP60GST and acetyl-CoA were incubated and the presence of acetylated BMAL1 was
detected by immunoblotting using either a pan-acetyl-Lys or a Lys538-specific
AcBMAL1 antibody. (E) Nuclear localization of TIP60V5 and BMAL1. Tip60-/- MEFs
stably expressing Tip60V5 were stained with an antibody against anti-V5 and anti-BMAL1
and counterstained with DAPI. Scale bar: 10 µm (F) TIP60 and Lys538 acetylated
BMAL1 colocalize to chromatin. Western blotting of cytoplasmic (S2), nucleoplasmic
(S3) and chromatin (P3) protein fractions from Dex-synchronized MEFs (24 hours after
Dex) using the antibodies indicated. H4 (chromatin) and GAPDH (cytoplasmic)
antibodies were used to assess the purity of the fractions. (G) Immunoblot analysis of the
interaction between endogenous TIP60 with BMAL1 or BMAL1K538R. IPs from Dex-
synchronized MEFs (24 hours after Dex) nuclear extracts were immunoblotted with the
antibodies indicated. IgG and buffer (mock IP) served as negative controls. (H) ChIP
analysis of Tip60-/-; Tip60V5 MEFs using anti-V5 and anti-BMAL1 antibodies. The
diagram shows the 5’ region of the Dbp gene. E-boxes that bind CLOCK-BMAL1 at
exons 1 (E1), exon 2 (E2), and transcription start sites are shown. Horizontal lines
represent PCR-amplified genomic regions. The 3’ UTR region was used as a control (n =
3). All data are shown as mean ± SEM.
Figure 19: BMAL1 Is the Only Clock Protein Acetylated by TIP60.
(A - D) Screen for putative TIP60 substrates. TIP60V5 or TIP60C369A;E403Q;V5 were co-
expressed with putative TIP60 substrates CLOCKmyc and BMAL1myc (A), PER2myc (B),
CRY1myc (C), and CRY2myc (D) in HEK293T cells. Acetylation of putative substrates was
assessed using an anti-pan-AcK antibody.
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3.4 TIP60 Is Essential for a Functional Circadian Clock in the
Mouse
This unexpected discovery of a new potential regulator of the circadian clock prompted
our laboratory to generate conditional TIP60 mice to assess the in vivo function of this
enzyme and provide fibroblasts that were used to study the molecular effect of TIP60 on
the clock in vitro. Tip60fl/- mice carrying one conditional and one deleted allele of Tip60
(Figure 7) were mated to Syt10-CRE driver mice. This driver is strongly active in the
postmitotic neurons of the SCN (Husse et al., 2011) circumventing cell lethality
associated with TIP60-deficiency (Hu et al., 2009). All offspring carrying two copies of
the knock-in Cre allele (Syt10Cre/Cre Tip60fl/-) and half of the mice carrying one copy of
the knock-in Cre allele (Syt10Cre/+ Tip60fl/-) became immediately arrhythmic upon release
into constant darkness (DD) (Figure 20A and B). The rest of the Syt10Cre/+ Tip60fl/- mice
showed either longer (29 %) or normal (21 %) free-running periods. Such a Cre dosage
dependence was also observed with Syt10-CRE-mediated deletion of Bmal1fl/fl and,
therefore, characterizes this particular driver (Husse et al., 2011). Immunohistochemical
staining for TIP60 in the SCN showed nuclear signal, which was absent in arrhythmic
Syt10Cre/+ Tip60fl/- mice (Figure 20C). Moreover, circadian expression patterns of Per1,
Dbp, and Bmal1 in the SCN were severely dampened (Figure 20D) in line with the
behavioral arrhythmicity observed in these animals. DAPI staining of SCN sections from
Syt10Cre/+ Tip60+/+ and arrhythmic Syt10Cre/+ Tip60fl/- mice showed no obvious changes
in SCN morphology or in the number of SCN cells (control: 827 ± 60 cells per section;
mutant: 850 ± 68 cells per section). In addition, no TUNEL signal, indicating apoptotic
cells, could be detected in the SCN of TIP60-deficient animals (Figure 20E). Together,
these experiments indicate that SCN cells were fully viable after deletion of Tip60.
The essential circadian function of TIP60 was also seen in MEFs. Immortalized MEFs
were prepared from Tip60fl/- mouse embryos and were transduced with a Bmal1-LUC
reporter. Confluent, i.e. non-dividing MEFs, were infected with AdCre to delete TIP60.
Cell confluency is sufficient to induce cell cycle quiescence (Hayes et al., 2005), thus
bypassing the role of TIP60 in cell cycle regulation (Sykes et al., 2006; Tang et al., 2006).
In TIP60-deficient MEFs, Lys538 acetylation of endogenous BMAL1 was markedly
reduced (Figure 21A and B), illustrating the crucial role of TIP60 in BMAL1 acetylation.
When endogenous TIP60 was replaced by TIP60C369A;E403Q in the Bmal1-LUC reporter
cell line, luciferase rhythms and mRNA rhythms of endogenous Dbp were abolished
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Figure 20: TIP60-deficiency Evokes a Circadian Phenotype in Mice and Disrupts
Rhythmic Clock Gene Expression in the SCN.
(A) Double-plotted actograms of control (Syt10Cre/+ Tip60+/+) and mutant (Syt10Cre/+
Tip60fl/-, Syt10Cre/Cre Tip60fl/-) mice under 12-hour/12-hour light-dark and constant
darkness conditions. Grey shadings indicate dark phases. (B) Free-running periods
determined by χ2 periodogram analysis. AR: arrhythmic (***p < 0.001, one-way
ANOVA with Bonferroni post-test). (C) TIP60-immunoreactivity (ir) in the SCN of
control (Syt10Cre/+ Tip60+/+) and arrhythmic mutant (Syt10Cre/+ Tip60fl/-) mice. (D)
Densitometric quantification of clock gene mRNA expression from radioactive in situ
hybridization analysis of control (Syt10Cre/+ Tip60+/+; black) and mutant (Syt10Cre/+
Tip60fl/-; red) SCN sections (n = 3; two-way ANOVA, see Table 13). (E) TUNEL
immunoreactivity on brain sections of control (Syt10Cre/+ Tip60+/+), arrhythmic
(Syt10Cre/+ Tip60fl/-) animals, and mutant (Syt10Cre/+ Tip60fl/-) sections treated in situ with
DNase I.
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Figure 21: TIP60-deficiency Disrupts Rhythmic Clock Gene Expression in MEFs.
(A and B) IPs from nuclear extracts (A) and nuclear extracts (B) from AdGFP (control)
and AdCre (mutant) transduced unsynchronized Tip60fl/- MEFs (two-fold dilutions) were
immunoblotted with antibodies indicated and signal intensities were quantified and
normalized (n=3). (C) Tip60fl/-; Bmal1-LUC MEFs stably expressing TIP60V5 (red),
TIP60C369A;E403Q;V5 (blue) or empty vector (black, coinciding with the blue tracing) were
transduced with AdCre and bioluminescence was recorded (n=4). (D) Dbp expression
profiles in TIP60V5 and TIP60C369A;E403Q;V5 cells shown in (C). (n=3; two-way ANOVA,
see Table 14). (D) Bioluminescence recordings of synchronized Tip60fl/-; Bmal1-LUC
MEFs transduced with AdGFP (black) or AdCre (red) (n=4). (F) mRNA expression
analysis of Dex-synchronized Tip60fl/- MEFs transduced with either AdGFP (black) or
AdCre (red) (n = 3; two-way ANOVA, see Table 15). (G) mRNA expression of
housekeeping and immediate early genes in Tip60fl/- MEFs transduced with either AdGFP
or AdCre, 24 hours after Dex synchronization (n = 3; ns > 0.05 and ***p < 0.001,
Student’s t-test). (H) Flow cytometric analysis of AdGFP, AdCre transduced, and heat-
treated (3 min, 95 °C) confluent Tip60fl/- MEFs. (I) Bioluminescence tracing of Dex-
synchronized Bmal1-LUC MEFs transduced with AdGFP (black) or AdCre (red) (n=4).
All data are shown as mean ± SEM.
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(Figure 21C and D). Deletion of Tip60 also resulted in a major dampening of the rhythmic
expression of the luciferase reporter (Figure 21E) and exhibited a strongly reduced
expression of endogenous clock genes (Figure 21F) but not of several housekeeping genes
(Figure 21F and G). Even the expression of c-Fos and c-Jun, two immediate-early genes,
was only slightly augmented (Figure 21G). Genetic manipulation of cells typically result
in a strong induction of immediate-early genes (Zhou et al., 2007). The deletion of TIP60
in confluent MEFs did not affect cell viability (Figure 21H) nor did adenoviral
transduction itself alter the circadian rhythm of a luciferase reporter (Figure 21I). Thus,
abrogation of TIP60 function has major effects on locomotor activity and the rhythmic
expression of clock genes in the SCN in vivo and in postmitotic MEFs highlighting the
key role of TIP60 in the circadian clock and clock gene transcription.
3.5 TIP60 Controls Productive Elongation of Circadian Transcripts
The severe circadian phenotype in the mouse (Figure 20), the strong changes of clock
gene expression in TIP60-deficient SCN and MEFs (Figure 20 and Figure 21), the TIP60-
mediated acetylation of BMAL1 at Lys538 (Figure 18), and the abrogated interaction
between BMAL1K538R with BRD4 and P-TEFb (Figure 15), all suggest that deletion of
TIP60 should prevent BRD4-P-TEFb recruitment and RNA Pol II pause release. Indeed,
in confluent TIP60-deficient Dex synchronized fibroblasts, BMAL1 was hypoacetylated
(Figure 21A and Figure 22A) and there was a major loss of interaction between BMAL1
and BRD4 (Figure 22A and B) as well as between BMAL1 and CDK9 (Figure 22C).
ChIP experiments showed that enrichment of BRD4 and CDK9 at the TSS of Dbp, Per1,
and Rev-Erbα genes was strongly reduced and Ser2-phosphorylated RNA Pol II
occupancy was diminished (Figure 22D). Of note, deletion of Tip60 did not affect TFIIEα
recruitment to the TSS of Dbp, Per1, and Rev-Erbα genes (Figure 22E). This suggests
that TIP60, like acetylation of BMAL1 (Figure 17), plays an important role in
transcription elongation rather than initiation.
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Figure 22: TIP60 Controls Productive Elongation.
(A) Interaction of BMAL1 with BRD4 in Tip60fl/- MEFs transduced with either AdGFP
(control) or AdCre (mutant). Immunoblots show results with increasing equivalents of
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IPs (two-fold dilutions) from nuclear extracts isolated from cells 24 hours after Dex
synchronization. (B and C) BRD4 (B) or CDK9 (C) IPs from AdGFP or AdCre
transduced Tip60fl/- MEF nuclear extracts were immunoblotted with antibodies indicated.
Analyses were carried out 24 hours after Dex synchronization. (D) ChIP analysis for
BRD4, CDK9 and Ser2P-RNA Pol II (normalized to total RNA Pol II) in the promoter or
the 3’-end of Dbp, Per1, and Rev-Erbα genes for the cells shown in (A). (E) TFIIEα ChIP
analysis of Dex-synchronized Tip60fl/- MEFs transduced with either AdGFP or AdCre.
All data are shown as mean ± SEM (n=3). Numerical values represent intensities of
chemiluminescence signals of individual bands, normalized to wildtype and loading
control for input samples.
3.6 CRYs Oppose TIP60 and Repress Productive Elongation of
Circadian Transcripts
Collectively, the data presented so far provide evidence that TIP60-mediated acetylation
of BMAL1 is an essential element of the positive limb of the circadian clock oscillator.
TIP60-mediated acetylation of BMAL1 leads to the recruitment of BRD4 and of the pause
release factor P-TEFb to clock gene TSSs. This, in turn, allows productive elongation of
CLOCK-BMAL1-controlled genes. This positive limb of the circadian cycle is
counteracted by a negative feedback mediated through PER and CRY proteins. This raises
the question of whether and how these repressors could interfere with BRD4-P-TEFb
recruitment and RNA Pol II pause release. One possibility is that nuclear accumulation
of TIP60 is time-dependent, with a nadir at the end of the positive limb. Western blot
analysis of nuclear lysates showed that this was not the case (Figure 24C). Alternatively,
TIP60 could be displaced from the promoters by the negative regulators PERs and CRYs.
CRY1 and CRY2 dynamically interact with the C-terminal transactivation domain of
BMAL1 (Kiyohara et al., 2006; Sato et al., 2006; Xu et al., 2015) that comprises Lys538
that is acetylated by TIP60 and interacts with BRD4. To test this hypothesis, HEK293
cells were co-transfected with Bmal1-myc, Tip60-V5, and with increasing amounts of
either Cry1-flag or Cry2-V5. Both CRY1 and CRY2 out-competed TIP60 for binding to
BMAL1 (Figure 23A and B). Furthermore, both CRY proteins markedly reduced
acetylation of BMAL1 (Figure 23A and B). Binding competition and substrate acetylation
were dose-dependent. PER2, on the other hand, did not affect the binding of TIP60 to
BMAL1 and the acetylation status of the transcription factor (Figure 23C). CLOCK-
mediated acetylation of BMAL1 was also reported to facilitate recruitment of CRY1 to
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Figure 23: CRYs Compete with TIP60 for BMAL1 Binding.
(A - C) BMAL1myc IPs from transiently transfected HEK293T cells overexpressing
BMAL1myc and TIP60V5 together with increasing amounts of CRY1FLAG (A) and CRY2V5
(B) or steady amount of PER2myc (C). IPs were analyzed for the acetylation state of
Lys538 of BMAL1 and binding of TIP60V5 in response to CRY1flag, CRY2V5, or PER2myc.
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(D and E) Interaction of CRY1FLAG (E) or CRY2V5 (F) with BMAL1myc, BMAL1K538R;myc,
and BMAL1K538Q;myc in transiently transfected HEK293T cells. Lysates were subjected
to IPs and immunoblotted with antibodies indicated. (F) ChIP analysis for control, Cry1,
and Cry2 siRNA-depleted Tip60-/-; Tip60V5 MEFs at the promoters of Dbp, Per1, and
Rev-Erbα genes for the proteins indicated. Data are shown as mean ± SEM (n = 3; *p <
0.05, **p <0.01, and ***p < 0.001, one-way ANOVA with Bonferroni post-test, relative
to siCtr).
the CLOCK-BMAL1 heterodimer, thereby promoting transcriptional repression
(Hirayama et al., 2007). However, no difference in the interaction between CRY proteins
with wildtype, non-acetylable (K538R), and acetyl-mimicking (K538Q) version of
BMAL1 was detected (Figure 23D and E). Thus, CRY proteins seem to play a unique
role in sequestering BMAL1 from the acetyltransferase TIP60, thereby regulating the
acetylation status of BMAL1. To test whether this competition occurred directly on
chromatin, CRY proteins were depleted by RNAi in MEFs in which endogenous TIP60
had been replaced by TIP60V5. CRY depletion led to an increased occupancy of TIP60V5
and of acetylated BMAL1 at the promoters of Dbp, Per1, and Rev-Erbα genes (Figure
23F). In CRY-deficient fibroblasts (CryDKO) the interaction between TIP60 and
BMAL1 was markedly enhanced and acetylation of BMAL1 was strikingly upregulated
(Figure 24A and C). Moreover, the interaction of BMAL1 with BRD4 was strongly
augmented in the CryDKO fibroblasts (Figure 24A). CRY-mediated control of BMAL1
acetylation was not limited to fibroblasts but also occurred in the liver. In CRY-deficient
liver samples, BMAL1 acetylation was strongly upregulated (Figure 25A). ChIP analysis
revealed that acetylated BMAL1, BRD4, and CDK9 were highly abundant at the
promoters of Dbp, Per1, and Rev-Erbα genes in CryDKO fibroblasts (Figure 24B) and
Ser2-phosphorylated RNA Pol II was markedly increased (Figure 24B). A strong
enrichment of acetylated BMAL1 at the promoters of Dbp, Per1, and Rev-Erbα genes
was also observed in CRY-deficient liver samples (Figure 25B). Consistent with previous
work, Dbp, Per1, and Rev-Erbα mRNA levels were upregulated in CryDKO fibroblasts
(Figure 24B) and CRY-deficient liver samples (Figure 25B) (Liu et al., 2007; Oishi et al.,
2003). Taken together, these data support a general mechanism by which CRY proteins
exert their inhibitory effect by preventing TIP60 from acetylating BMAL1, thereby
repressing BRD4-P-TEFb recruitment and productive elongation.
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Figure 24: CRYs Control Transcription Elongation.
(A) Interaction of BMAL1 with BRD4 and TIP60 in control or CRY-deficient (CryDKO)
fibroblasts. Immunoblots show results with increasing equivalents of IPs (two-fold
dilutions) from nuclear extracts harvested from unsynchronized cells. Numerical values
represent intensities of chemiluminescence signals of individual bands, normalized to
wildtype and loading control for input samples. (B) ChIP (bottom) and mRNA (top)
analysis of unsynchronized wildtype and CryDKO fibroblasts. ChIP shows enrichment
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of BMAL1, acetylated BMAL1, BRD4, CDK9, and Ser2P-RNA Pol II (normalized to
total RNA Pol II) at the promoter or 3’-end (Ser2P-RNA Pol II and RNA Pol II) of Dbp,
Per1, and Rev-Erbα genes. Data are shown as mean ± SEM (n = 3; **p < 0.01, and ***p
< 0.001, Student’s t-test). (C) Immunoblot analysis of wildtype and CryDKO fibroblasts
nuclear extracts and BMAL1 IPs over a 24-hour time course with antibodies indicated.
Figure 25: CRYs Control Lys538 Acetylation of BMAL1 in the Liver.
(A) Immunoblot analysis of wildtype and CRY-deficient liver nuclear extracts and
BMAL1 IPs over a 24-hour time course with antibodies indicated. (B) ChIP (bottom) and
mRNA (top) analysis of wildtype and CRY-deficient liver samples carried out at CT8 and
CT20. ChIP shows enrichment of BMAL1 and acetylated BMAL1 at the promoter of
Dbp, Per1, and Rev-Erbα genes. Data are shown as mean ± SEM (n = 3).
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3.7 Rhythmicity of Productive Elongation of Circadian Transcripts
TIP60 can access BMAL1 at the promoters during the positive limb of the clock cycle,
but when CRYs are abundant during the negative limb, this access is hindered. This
interplay between positive and negative regulation, characteristic for the circadian cycle,
should also be seen in temporal occupancy profiles of pause release indicators at the
promoters of E-box-controlled clock genes. In wildtype fibroblasts, the peak of
interaction between TIP60 and BMAL1 occurred approximately 24 hours after
synchronization of the cells (Figure 24C) (activation phase). During this phase, the
strongest enrichment of BMAL1 and of acetylated BMAL1 at the promoters of Dbp,
Per1, and Rev-Erbα genes was observed (Figure 26A, green). The concentration of
acetylated BMAL1 in nuclear extracts also showed its maximum by that time (Figure
26B). The occupancy of BRD4 also peaked at target gene promoters (Figure 26A) and
Ser2 phosphorylation of RNA Pol II showed a peak (Figure 26A) at that time.
Consequently, the abundance of Dbp, Per1, and Rev-Erbα mRNA peaked between 24-
28 h (Figure 26A). A similar situation was also be observed in the wildtype liver. The
peak of acetylated BMAL1 occurred at circadian time (CT) 8 (Figure 25A), a time period
that falls into the activation phase (Koike et al., 2012). During that time, the strongest
enrichment of BMAL1 and of acetylated BMAL1 at the promoters of Dbp, Per1, and
Rev-Erbα genes was observed (Figure 27A) and expression of Dbp, Per1, and Rev-Erbα
showed its maximum (Figure 27A). Of note, CRY proteins peak later in the circadian day
and thus cannot substantially interfere with BRD4 recruitment, RNA Pol II pause release
and productive elongation in the fibroblasts (Figure 26A). The gradual rise of nuclear
CRY proteins (Figure 26B) and of Dbp promoter associated CRY1 (Figure 26C) seen
during the repression phase was accompanied by a reduction of the interaction of TIP60
with BMAL1 (Figure 24C), a decline of chromatin-bound acetylated BMAL1, a reduction
of BRD4 recruitment to circadian promoters, a drop of Ser2-phosphorylated RNA Pol II
and a dampening of E-box-controlled gene expression (Figure 26A, red). Such a CRY
dependent reduction of BMAL1 acetylation was also observed in wildtype liver. The rise
of nuclear (Figure 25A) and chromatin associated (Figure 27B) CRY1 protein seen during
the repression phase was accompanied by a reduction of chromatin-bound acetylated
BMAL1 (Figure 27A) and dampening of Dbp, Per1, and Rev-Erbα expression (Figure
27A). Thus, control of BMAL1 acetylation by CRY proteins appears to be a general
mechanism of CRY-mediated repression that is not limited to fibroblasts. Taken together,
the data show that TIP60-dependent BRD4 recruitment, RNA Pol II pause release,
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productive elongation, and the opposing effects of chromatin associated CRY proteins on
transcription are precisely timed over the circadian cycle and in this way exert a temporal
control over the circadian clock oscillator.
Figure 26: Rhythmic Profile of Productive Elongation.
(A) ChIP profiles of Dex-synchronized MEFs over a course of 24 hours. ChIP analysis
show time-of-day-dependent enrichment of BMAL1, acetylated BMAL1, BRD4, and
Ser2P-RNA Pol II (normalized to total RNA Pol II) at the promoter or 3’-end (Ser2P-
RNA Pol II and RNA Pol II) of Dbp, Per1, and Rev-Erbα genes. The rightmost column
reveals time-dependence of mRNA accumulation for these genes. (B) Immunoblot
analysis with the indicated antibodies of Dex-synchronized fibroblast nuclear extracts and
BMAL1 IPs. (C) ChIP analysis of acetylated BMAL1 and CRY1 for the Dbp promoter
in Dex-synchronized MEFs over a course of 24 hours. All data are shown as mean ± SEM
(n = 3). The color bars represent the activation (green) and repression (red) phases of the
circadian cycle.
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Figure 27: Rhythmic Profile of BMAL1 Acetylation in the Liver.
(A) Time-of-day-dependent enrichment of BMAL1 and acetylated BMAL1 at the
promoter of Dbp, Per1, and Rev-Erbα genes in the liver. The rightmost column reveals
time-dependence of mRNA accumulation for these genes. (B) ChIP analysis of acetylated
BMAL1 and CRY1 for the Dbp promoter in wildtype liver over a course of 24 hours. All
data are shown as mean ± SEM (n = 3).
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Data from genome-wide ChIP studies (Koike et al., 2012; Menet et al., 2012; Rey et al.,
2011) in particular, Koike et al. propose that at the onset of the circadian cycle, the
repressor CRY1 is associated with the chromatin-bound CLOCK-BMAL1 located near
RNA  Pol II. In this complex RNA Pol II is bound to the clock gene promoters but is not
competent to drive RNA synthesis. Upon degradation of CRY1, coactivators (e.g. p300)
are recruited to the CLOCK-BMAL1 heterodimer complex, followed by transcription of
circadian clock genes encoding CRY and PER repressor proteins. To ensure the precision
of the circadian clock, transcription needs to be accurately timed and synchronous across
a population of cells. Although promoter proximal pausing is a regular step of the
transcription cycle, the release of this process can be a crucial regulatory step in
transcriptional activation of certain gene classes. Thus, promoter proximal pausing and
release into productive elongation offer a mechanism capable to accurately time
transcription (Core and Adelman, 2019; Jonkers and Lis, 2015; Liu et al., 2015). Evidence
for RNA Pol II pausing to occur at circadian promoters can be found in global run-on
sequencing (GRO-Seq) analyses measuring transcriptionally engaged RNA Pol II during
the circadian cycle (Fang et al., 2014). In this study, a sharp peak of RNA Pol II
downstream of the TSS of the Rev-Erbα gene was detected during the repression state,
raising the possibility that RNA Pol II is in a paused state at this particular promoter.
Furthermore, genome-wide ChIP experiments (Koike et al., 2012) reveal a peak of RNA
Pol II Ser5 phosphorylation at a time when the CLOCK-BMAL1-CRY1 complex is
associated with circadian promoters near transcriptionally paused RNA Pol II. Such RNA
Pol II Ser5 phosphorylation is a main indicator for promoter-proximal pausing (Harlen
and Churchman, 2017). In addition, genome-wide and time-resolved quantitative analysis
of RNA Pol II abundance around TSS regions and gene bodies show a peak of RNA Pol
II binding near the TSS of clock genes at the same time when the CLOCK-BMAL1-
CRY1 complex orchestrates circadian promoters (Zhu et al., 2018). Thus, the RNA Pol
II peaks at the TSS of clock genes, at the onset of the circadian cycle, likely represent
paused RNA Pol II. A recent study using data from various published sources and
mathematical modeling also suggests that, at least for strong circadian promoters, RNA
Pol II release could be a critical regulatory step of circadian transcription (Westermark,
2016). The present work now provides both, experimental evidence and mechanistic
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insights into circadian regulation of RNA Pol II pause release and suggests that this
process could be an important regulatory step of the mammalian circadian clock.
This study proposes that TIP60 acetylates BMAL1 on-chromatin which then triggers the
recruitment of the co-activator BRD4 to the acetylated transcription factor BMAL1 and
hence to clock gene promoters. BRD4 recruits the pause release factor P-TEFb, whose
kinase subunit CDK9 phosphorylates Ser2 of RNA Pol II leading to a release of RNA Pol
II from the paused state enabling productive elongation of E-box-containing clock genes
(Figure 28). For this sequence of events multiple lines of evidence are provided. (1) In
TIP60-deficient cells, Lys538 acetylation of BMAL1 was strongly diminished leading to
abolishment of BRD4-P-TEFb recruitment to Dbp, Per1, and Rev-Erbα genes and
prevention of RNA Pol II pause release. (2) In BMAL1K538R cells, in which Lys538 was
replaced by an arginine, even though TIP60 was still recruited to the mutated protein, the
interaction between BMAL1 and BRD4-P-TEFb was abrogated, preventing RNA Pol II
pause release and productive elongation. (3) Pharmacological inhibition of BRD4
abolished BRD4-P-TEFb recruitment to circadian promoters and consequently impaired
RNA Pol II pause release of E-box-containing clock-controlled genes. (4) The
dysregulation of the circadian rhythm of locomotor activity in the mouse and perturbation
of circadian gene expression in the SCN and in MEFs provide strong genetic evidence
Figure 28: Model of RNA Pol II Pause Release Control at E-box-containing Clock
Genes.
This study provides evidence that the positive and negative phases of the circadian
oscillator are linked through TIP60. The circadian clock cycle is initiated by CLOCK-
BMAL1 binding to E-boxes of clock genes followed by a TIP60-mediated acetylation of
chromatin bound BMAL1, which then triggers the recruitment of BRD4. BRD4 recruits
P-TEFb, whose kinase subunit CDK9 phosphorylates Ser2 of RNA Pol II leading to a
release of RNA Pol II from the paused state enabling productive elongation. During the
repression phase, when CRY proteins are highly abundant at clock gene promoters,
transcription elongation ceases, most likely by sequestering BMAL1 from TIP60 and
prevention of TIP60-driven acetylation of BMAL1.
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for a key role of TIP60 in the circadian clock. Taken together, these lines of evidence
suggest that rhythmic control of RNA Pol II pause release may be a main process
involving TIP60. Furthermore, the study illustrates that RNA Pol II pause release is an
additional regulatory step that contributes to the temporal control of the mammalian
circadian clock.
The transcription cycle consists of several sequential steps that are regulated in response
to cellular signals or cues (Core and Adelman, 2019). First of all, TSSs must be made
accessible to the transcription machinery, which often requires cooperation between
transcription factors and chromatin modifiers and remodelers. The evidence that this also
applies to CLOCK-BMAL1 comes from a genome-wide ChIP study showing that the
histone acetyltransferase p300/CBP has many common binding sites with the CLOCK-
BMAL1 heterodimer (Koike et al., 2012). Furthermore, CLOCK-BMAL1 was reported
to interact with BRG1 (Brahma-related gene 1), the catalytic subunit of the mammalian
SWI/SNF (SWItch/Sucrose Non-Fermentable) chromatin-remodeling complex (Kim et
al., 2014). Although first studies using a computational approach in combination with
genome-wide RNA Pol II ChIP data concluded that RNA Pol II pausing plays a negligible
role in circadian transcription regulation (Le Martelot et al., 2012), accumulation of RNA
Pol II observed at TSSs of clock-controlled genes clearly shows that the release from
promoter proximal pausing is a rate limiting step in the transcription cycle of these genes.
This is also supported by a recent computational study using a multitude of circadian
genome-wide datasets showing that transcription initiation in combination with RNA Pol
II pause release are essential for strong rhythmic clock gene expression (Westermark,
2016). Thus, CLOCK-BMAL1 plays a multifaceted role during transcription activation.
It does not only regulate transcription initiation (Koike et al., 2012; Le Martelot et al.,
2012) but also regulates RNA Pol II pause release after TIP60-mediated acetylation, as
illustrated in this study. One advantage of the separate regulation of transcription
initiation and RNA Pol II pause release is that signaling pathways can influence one or
both steps, enabling the integration of conflicting or magnifying signals (Figure 29) (Core
and Adelman, 2019). The result is a dynamic and precise control of gene expression that
can be found in a variety of biological processes such as immune responses, hormone
signaling, or early development (Core and Adelman, 2019). Binding of CLOCK-BMAL1
to the promoters of clock-controlled genes is therefore not sufficient to induce strong
rhythmic gene expression and requires an addition signal in the form of the
acetyltransferase TIP60. This could also explain why CLOCK-BMAL1 binding to the
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DNA not always results in rhythmic gene expression and shows divergent transcriptional
output (Koike et al., 2012; Menet et al., 2012; Rey et al., 2011) and why nuclear amount
of BMAL1 is lowest during the activation phase (Lee et al., 2001). Thus, not the mere
presence of BMAL1 is essential for the transcriptional output of the transcription factor,
but its correct posttranslational modification. This bimodal regulation of circadian
transcription regulation could also allow the integration of environmental cues to entrain
the system to the new zeitgeber such as light, temperature, and food. Thus, CLOCK-
BMAL1 not only appears to be involved in the initial stages of RNA Pol II recruitment
and initiation (Koike et al., 2012; Le Martelot et al., 2012) but also controls RNA Pol II
pause release to determine the ultimate transcriptional output of the clock-controlled
genes.
Figure 29: Transcription factors can control initiation and/or RNA Pol II pause
release.
(A) Recruitment of P-TEFb by a TF is not sufficient to activate gene transcription. (B)
TF-mediated stimulation of transcription initiation will result in low level of gene
expression. (C) Stimulation of both initiation and RNA Pol II pause release are essential
for strong and rapid gene activation. Figure adapted from Core and Adelman (2019).
TIP60 is evolutionarily highly conserved and is involved in the regulation of a series of
cellular processes (see introduction). Thereby, TIP60 has mainly the role of an
enzymatically active cofactor in larger multiprotein complexes (Jacquet et al., 2016;
Judes et al., 2015). This study suggests a similar function of TIP60 within the circadian
clock. Although TIP60 deficiency leads to a severe circadian phenotype, the mechanism
that is proposed would classify TIP60 as a coactivator/cofactor and not as a core clock
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protein. Furthermore, the study leaves open the question of whether TIP60 is recruited
alone or in a larger complex to CLOCK-BMAL1. TIP60 is an essential protein whose
deletion results in early embryonic lethality at the blastocyst stage (Hu et al., 2009). In
contrast, TIP60 acetyltransferase mutant mice, encoding amino acid substitutions in the
active site, exhibit developmental defects later than TIP60 null mutant mice. This
emphasizes that not all functions of the TIP60 complex rely on its acetyltransferase
activity but the acetyltransferase-independent regulation of gene expression also plays an
important role (Acharya et al., 2017). In addition to the acetyltransferase TIP60, the TIP60
complex harbors another subunit with chromatin remodeling activity. The p400 protein
catalyzes ATP-dependent incorporation of histone variant H2A.Z or H3.3 into chromatin
(Gévry et al., 2007; Mizuguchi et al., 2004; Pradhan et al., 2016). Both histone variants
are often enriched around TSSs promoting recruitment of RNA Pol II and gene activation
(Melters et al., 2015). CLOCK-BMAL1 binding at clock-controlled gene promoters
strongly correlates with rhythmic changes in H2A.Z occupancy and BMAL1-deficency
results in a severe loss of H2A.Z deposition at these sites (Menet et al., 2014). Thus,
recruitment of TIP60 complex to E-box bound CLOCK-BMAL1 could lead to two
distinct events, the acetylation of BMAL1 by TIP60 and the ATP-dependent
incorporation of H2A.Z at the TSSs by p400. Consequently, the TIP60 complex could
control both RNA Pol II recruitment to the TSSs of clock-controlled genes and the RNA
Pol II pause release and productive elongation of these genes.
Although it has been proposed that acetylation of BMAL1 at Lys538 by CLOCK peaks
within the repression phase and enables recruitment of CRY proteins (Hirayama et al.,
2007) the data presented here do not support this claim. This study shows that TIP60-
mediated acetylation of BMAL1 occurs during the activation phase of the clock cycle, a
phase when CRY proteins are low abundant. This is in line with the latest data from the
Sassone-Corsi laboratory (Koronowski et al., 2019; Nakahata et al., 2008; Welz et al.,
2019). Co-immunoprecipitation experiments did also not show any differences in the
interaction of BMAL1 or BMAL1K538R with CRY proteins, arguing against the proposed
model by Hirayama and co-workers (Hirayama et al., 2007). A recent study using a mouse
model that reconstitutes only the hepatic clock in an otherwise clock-deficient animal
(Koronowski et al., 2019) showed that peak of BMAL1 acetylation is phase advanced by
approximately 4 hours compare to wildtype liver. Interestingly, recruitment of BMAL1
to the promoters of Dbp and Per1 and the expression of these genes was also phase
advanced, underlining the importance of BMAL1 acetylation during the activation phase.
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The finding of strong acetylation of Lys538 of BMAL1 in CLOCK-deficient fibroblasts
and the absence of an effect on the BMAL1 acetylation status in a reaction with a
catalytically inactive CLOCK mutant protein raises also some doubt about the efficiency
of CLOCK as an acetyltransferase for BMAL1. A slight increase in BMAL1 acetylation
after transfection of wildtype or acetyltransferase deficient CLOCK (Figure 18A)
supports the idea that the formation of a CLOCK-BMAL1 complex favors the recruitment
of acetyltransferases such as TIP60. Thus, the enhanced histone acetyltransferase activity
of CLOCK after co-transfection with BMAL1 (Doi et al., 2006) might be the result of
augmented TIP60 recruitment. It is noteworthy that CLOCK acetylates argininosuccinate
synthase in the cytosol of U2OS cells (Lin et al., 2017). Since the experiments conducted
in this study are aimed at the transcriptional regulation of the clock, they were carried out
with nuclear extracts and do not address the cytosolic acetyltransferase activity of
CLOCK.
Cells express a multitude of acetyltransferases including TIP60 and CBP/p300.
CBP/p300 was reported to directly bind and mediate the transactivation activity of
BMAL1 (Etchegaray et al., 2003; Koike et al., 2012; Takahata et al., 2000). However, in
fibroblasts, but also in the SCN, deletion of TIP60 resulted in a nearly complete loss of
rhythmic expression of numerous circadian genes suggesting that in these tissues and for
these genes TIP60 function is non-redundant. Although it has been reported that p300
acetylates BMAL1, it does this at Lys500 and not at Lys538 (Weinert et al., 2018). It
cannot be ruled out that p300 and TIP60 could act cooperatively and promote the
acetylation of BMAL1 (Xiao et al., 2014). However, recombinant TIP60 was able to
acetylate BMAL1 in vitro, arguing that BMAL1 is a direct substrate of TIP60. The
abundance of BRD4 at clock gene promoters was drastically reduced in BMAL1K538R
cells, but it is likely that there are other substrates that are acetylated including histones
H3 and H4 present at promoters of circadian genes (DiTacchio et al., 2011; Etchegaray
et al., 2003; Koike et al., 2012; Ripperger and Schibler, 2006; Vollmers et al., 2012), to
which BRD4 could also be recruited and affect the circadian clock.
Previous studies showed that CRY proteins directly interact with CLOCK-BMAL1 and
are part of a larger Pol II-containing complex. The contacts between BMAL1 and CRY
proteins map to the C-terminal transactivation domain of BMAL1 (Kiyohara et al., 2006;
Sato et al., 2006; Xu et al., 2015) that also comprises Lys538 that is acetylated by TIP60.
Thus, CRY proteins have the opportunity to prevent TIP60-mediated acetylation of
BMAL1. That this is indeed the case in vivo, is illustrated in experiments with CRY-
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deficient and Cry1- and Cry2-depleted fibroblasts. In these cells, interaction between
TIP60 and BMAL1 was evidently not inhibited, resulting in a persistent Lys538
acetylation of BMAL1 throughout the circadian cycle. Such a loss of CRY function
massively boosted BRD4-P-TEFb recruitment to BMAL1 followed by RNA Pol II pause
release and the productive elongation of E-box-containing circadian genes. Conversely,
if CRY proteins were overexpressed, interaction between TIP60 and BMAL1 was
prevented, BMAL1 was hypoacetylated, BRD4-P-TEFb was not recruited, and
productive elongation was impaired. It thus appears that the negative feedback loop of
the circadian cycle involves, at least in part, a CRY-mediated repression of acetylation of
BMAL1 by TIP60 resulting in an obstruction of BRD4-P-TEFb recruitment and RNA
Pol II pause release. This study proposes that positive and negative signals converge on
the same molecular target (Figure 28).
The outstanding role of CRY1, within the molecular clock, is illustrated by the fact that
CRY1 plays a more indispensable role for rhythmic clock gene transcription than CRY2
and seems to have a stronger repressor capacity for CLOCK-BMAL1-mediated
transcription than its homolog (Khan et al., 2012; Rosensweig and Green, 2018). At a
behavioral level, CRY1 and CRY2 single knockout mice also show distinct differences
in period length (van der Horst et al., 1999; Vitaterna et al., 1999). While CRY1-deficient
mice illustrate shorter period, surprisingly, CRY2-deficient mice show longer period
under constant condition. Based on the prosed model, absence of CRY1 during the late
repression phase would allow TIP60 earlier to form a complex with CLOCK-BMAL1
and thereby reduce the time of promoter proximal pausing and accelerate the clock. Loss
of promoter proximal pausing and impaired synchronized expression of CLOK-BMAL1
controlled genes is probably also the reason why individual cells like fibroblast, SCN
neurons, or tissue explants from CRY1-deficient mice lack stable rhythms (Liu et al.,
2007; Wong et al., 2018). By contrast, in CRY2-deficient mice (a CRY1-driven clock),
CRY1 is more abundant in the nucleus and shows extended expression reaching into the
early circadian day (Stratmann et al., 2010). Thus, stabilization of CRY1 and prolongation
of promoter proximal pausing allows it to delay the onset of CLOCK-BMAL1-driven
transcription, thereby extending the limb of the negative feedback. Nuclear stabilization
of CRY-proteins either through pharmacological treatment with a small molecule named
KL001 (Hirota et al., 2012) or genetic manipulations (Foteinou et al., 2018; Godinho et
al., 2007; Patke et al., 2017; Siepka et al., 2007) were previously reported to slow down
the circadian clock likely by extending the pause duration time of RNA Pol II at E-box-
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driven clock genes. Tissue explants from CRY2-deficient mice show circadian rhythms
that are more robust und stable compared to wildtype counterparts (Liu et al., 2007; Wong
et al., 2018). An extension of promoter proximal pausing could lead to increased
synchronous expression of CLOCK-BMAL1-target genes and thereby enhance the
stability of the clock.
Binding of CRY-proteins to the genome is not restricted to CLOCK-BMAL1 binding
sites and extends to thousands of additional sites containing DNA-binding motifs for
nuclear receptors (Koike et al., 2012; Takahashi, 2017). CRYs were reported to broadly
interact with nuclear receptors and repress their transcriptional activity (Kriebs et al.,
2017; Lamia et al., 2011). Whether CRYs also fulfill their inhibitory function through
sequestering the transactivation domains of the hormone receptors and thereby regulate
RNA Pol II pause release requires further studies.
TIP60 acetylates BMAL1 during the activation phase, but it is not clear by which
mechanism BMAL1 is deacetylated during the repression phase. One possibility is a
SIRT1-dependent deacetylation of BMAL1 (Nakahata et al., 2008). Whereby recent
studies suggest that not BMAL1 but PER2 could be the direct substrate of SIRT1 (Asher
et al., 2008; Foteinou et al., 2018). This finding is consistent with the minor circadian
phenotype reported for SIRT1-deficiency at the tissue level (Chang and Guarente, 2013;
Wang et al., 2016). PER proteins recruit a wide variety of chromatin modifiers and
remodelers to the promoters of clock-controlled genes (Brown et al., 2005; Duong and
Weitz, 2014; Duong et al., 2011; Kim et al., 2014; Padmanabhan et al., 2012). One of the
chromatin modifiers is HDAC1 (Duong et al., 2011; Kim et al., 2014), that could directly
deacetylate BMAL1 during the early repression phase of the circadian cycle (Koike et al.,
2012). Acetylated BMAL1 could also be displaced from circadian promoters by PER
proteins in a CRY-dependent manner (Chiou et al., 2016; Ye et al., 2011, 2014).
Alternatively, promoter-associated acetylated BMAL1 could be subject to rapid
proteolytic turnover (Stratmann et al., 2012) obviating the need for a specific deacetylase.
A vast majority of strongly rhythmic CLOCK-BMAL1-target genes harbor a highly
conserved tandem E-box motif (E1-E2) that engages CLOCK-BMAL1 cooperatively and
favors strong binding and very precise, phase-specific gene expression (Rey et al., 2011;
Shimomura et al., 2013). Increased abundance of acetylated BMAL1 at the E1-E2 motifs
would recruit more BRD4-P-TEFb and allow efficient and synchronized pause release of
RNA Pol II. Dbp, Per1, and Rev-Erbα belong to this class of genes. This suggests that
regulation of RNA Pol II pause release could extend to the entire class of these E-box
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controlled clock genes. These genes are synchronously expressed and would benefit from
a precisely timed RNA Pol II pause release process. It is not clear, however, whether
BRD4-P-TEFb mediated RNA Pol II pause release applies for other types of clock genes.
Temporal analyses of RNA Pol II pause release at the transcriptome-wide scale will
address these issues.
Taken together, this study demonstrates that the TIP60-mediated acetylation of BMAL1
links the transcriptional activators CLOCK-BMAL1 and RNA Pol II-mediated
transcription of clock-controlled genes. Acetylation of BMAL1 leads to recruitment of
BRD4-P-TEFb to circadian promoters and allows RNA Pol II pause release and
productive elongation. CRY proteins prevent TIP60-mediated acetylation and thereby
repress BRD4-P-TEFb recruitment and productive elongation of E-box-containing
circadian transcripts. Hence, the positive and negative control of RNA Pol II pause release
are an important element of the circadian clockwork and could allow a precise and
synchronous expression of core clock-controlled genes and in this way also contribute to
robustness of the circadian clock. This added layer of regulation could also provide a
temporal window to integrate signals and possibly regulate the magnitude of
transcriptional output. Robust and synchronous expression are the hallmarks of genes
involved in stimulus-controlled pathways, whose transcription is also often regulated
through Pol II pause release (Jonkers and Lis, 2015; Liu et al., 2015; Siegal and Rushlow,
2012). Uncovering the bromodomain-containing co-activator BRD4 as a main regulator
of the circadian clock could provide new therapeutic strategies to treat circadian clock-
related disorders (Wang and Filippakopoulos, 2015).
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In fibroblasts, but also in the SCN, deletion of TIP60 resulted in a nearly complete loss
of rhythmic expression of numerous circadian genes suggesting that in these systems and
for these genes TIP60 function is non-redundant. To extend the understanding of TIP60-
mediated RNA Pol II pause release, liver tissue was decided to be used for subsequent
analysis. The mouse liver is a relatively large, homogeneous tissue that is not only easily
accessible but also harbors a functional circadian clock that controls liver-specific gene
expression. Numerous genome-wide studies have used this organ to reveal the molecular
functions of various clock components and their temporal orchestration (Cho et al., 2012;
Fang et al., 2014; Feng et al., 2011; Koike et al., 2012; Rey et al., 2011).
The majority of the experiments in this study were performed with fibroblasts, leaving
open the question of whether the proposed mechanism of TIP60-mediated and CRY
counteracting control of RNA Pol II pause release also occurs in other tissues, such as the
liver. Although this study could show that acetylation of BAML1 occurs during the
activation phase and is negatively regulated by CRY proteins in the liver, it remains
unclear whether BMAL1 acetylation triggers BRD4-P-TEFb recruitment to E-box
containing clock genes. Another open question is whether TIP60 also acetylates BMAL1
in the liver. In order to shed some light on this question, Tip60fl/fl mice were crossed to
Alb-CRE driver mice. Tip60fl/fl Alb-Cre mice were viable, fertile and showed no obvious
abnormalities. The genome-wide transcriptional analysis of the liver of these animals will
not only make it possible to answer the above question, but also to uncover whether
TIP60-mediated control of RNA Pol II pause release applies for all E-box controlled clock
genes or only to a separate class of strongly rhythmic, phase specific CLOCK-BMAL1-
target genes that contain multiple E-boxes such as Dbp, Per1, and Rev-Erbα. Another
limitation of the current study was the insufficient mapping of TIP60 to the genome. To
overcome this problem and to investigate the temporal genome-wide binding of TIP60 to
DNA, LSL-Tip60-FLAG transgenic mice were generated (Figure 9). These mice were
then first mated to Tip60fl/fl mice and subsequently crossed to Alb-CRE driver mice.
Tip60fl/fl;LSL-Tip60-FLAG;Alb-Cre mice are deficient for TIP60 in the liver and instead
express a C-terminal FLAG-tagged version of TIP60 in this tissue. These mice were
viable, fertile and showed no obvious abnormalities. Temporal genome-wide ChIP-seq
analysis of TIP60FLAG will uncover direct TIP60 target genes and contribute to the
understanding of the on-chromatin competition of TIP60 and CRY proteins for BMAL1.
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